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1 Introduction 
1.1 The genetic transformation of plants  
A plant cell offers three genomes for genetic manipulation: the nuclear genome and the 
organellar genomes in the mitochondria and in the plastids. Stable genetic manipulation of a 
plant's nuclear genome was first reported in the early 1980s by Agrobacterium tumefaciens 
mediated transformation (Herrera-Estrella et al., 1983, Bevan et al., 1983). Today it represents a 
standard technique in many laboratories (Horsch et al., 1985, Clough and Bent, 1998).  
The technique does not require a sequenced DNA template of the target species (non-
homologous insertion) and is broadly applicable to a wide range of species (for review: Meyers et 
al., 2010). In contrast, the transformation of the organellar genomes is less established  
(Butow and Fox, 1990). Transformation of the mitochondrial genome is only reported in Yeast 
(Saccharomyces cerevisiae, Johnston et al., 1988) and Chlamydomonas reinhardtii, a unicellular 
green alga (Randolph-Anderson et al., 1993), but not in higher plants (Ijaz, 2010). Stable genetic 
transformation of a plastid genome (plastome) was first shown for Chlamydomonas reinhardtii 
(Boynton et al., 1988) and was successfully applied to the higher plant Nicotiana tabacum L. 
(tobacco) two years later (Svab et al., 1990). The technique of plastid transformation developed to 
an exciting research field with both basic and applied aspects (Koop et al., 2007). 
1.2 Plastid transformation 
Stable transformation of the plastid genome as a technique of manipulating a plant's DNA is 
considerably elegant. A key feature of the technology is the targeted insertion of transgenes in 
the plastome. This is based on the plastid's prokaryotic origin (Chan and Bhattacharya, 2010), 
which allows transformation vector integration based on homologous recombination.  
DNA sequences to be integrated into the plastome are therefore flanked by sequences amplified 
from the plastome of the target species. They are then subsequently incorporated at the specified 
site upon transformation vector delivery (Figure 1A). Although the plastomes of many species are 
sequenced (Verma et al., 2008) and substantial efforts are made towards stable transformation of 
those candidates (Herrera-Diaz, 2011), tobacco still represents the main model species in the 
field. For obvious candidates like the plant model Arabidopsis thaliana and monocot species of 
huge economic relevance like corn, rice, wheat etc. reproducible protocols are still elusive.  
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Transformation vectors are delivered to various explants by the biolistic method (Svab et al., 
1990) or to protoplasts by polyethylene glycol (Golds et al., 1993). Selection is commonly based 
on antibiotics resistance genes. Plastids are highly polyploid. The plastome copy number depends 
on plant species, tissue type and plastid number per cell – up to 10,000 plastome copies are 
present in tobacco leaf cells (Maliga, 2004). A successful transformation event involves a single or 
very few plastid DNA molecules initially which leads to cells with genetically different plastomes 
(Koop et al., 2007). This status of the cells is called heteroplasmic and these cells give rise to 
heteroplasmic shoots .This is the first regeneration event which emerges from tissue culture 
(Figure 1B). To sort out wild-type (WT) plastome copies, repeated rounds of regeneration under 
selection pressure are carried out. This leads to cells containing transformed plastome copies only  
(Figure 1C). The status of the resulting cells is called homoplasmic. Homoplasmic cells give rise to 
stably transformed transplastomic plants. Once homoplasmy is achieved, up to 10,000 copies of 
the new genetic information are present, offering the possibility to yield high protein 
accumulation levels. 
 
Figure 1. Events from the biolistic transformation vector delivery to the regeneration of a homoplasmic plant. 
 (A) Expression cassettes (PL_aadA_T) are flanked by homologous plastome sequences (INSR, INSL) for site-specific 
integration via homologous recombination. PL: promoter+leader (5’ regulatory region for trancription and translation), 
aadA: spectinomycin resistance cassette used for the selection of successful transformation events, T: terminator 
(3’ regulatory region). (B) Repeated rounds of regeneration under selection pressure lead to homoplasmic 
transformants. (C) Sorting out WT plastome copies under selection pressure (S) to obtain mutant copies only. Modified 
from Bock and Khan, 2004, and Cardi et al., 2010. 
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Due to their prokaryotic origin, plastids can be used for the expression of polycistronic operons 
(Staub and Maliga, 1995). Public concerns connected with genetic manipulation can be accounted 
for by the use of inducible systems (Lössl et al., 2005, Mühlbauer and Koop, 2005, Verhounig et 
al., 2010) and antibiotic selection marker removal strategies (for review: Day and Goldschmidt-
Clermont, 2011). Compared to nuclear transformants, transplastomic plants are save to grow in 
the field since plastids are maternally inherited in most crops (Corriveau and Coleman, 1988). 
It is therefore unlikely that the foreign sequence will escape to wild relatives. However, small 
scale leakage was observed (Ruf et al., 2007, Svab and Maliga, 2007) and long-time effects of such 
scenarios need to be investigated in the future. 
1.3 Current applied aspects of plastid transformation  
In basic science, plastid transformation is used to study plastid function e.g. by the mutation or 
inactivation of plastid genes (Mühlbauer et al., 2002). Applied aspects cover the establishment of 
novel traits in the plant. This may involve the introduction of new single traits e.g. herbicide 
resistance (McBride et al., 1995), but also biosynthetic pathways can be modified or newly 
introduced (Apel and Bock, 2009, Krichevsky et al., 2010). Recent reviews provide more 
information about the current field (Koop et al., 2007, Verma and Daniell, 2007, Maliga and Bock, 
2011). One major research branch of plastid transformation is based on the plastid's capacity to 
accumulate large amounts of proteins: the expression of therapeutics for human health, like 
antibodies, vaccines and more recently various antimicrobials (Daniell et al., 2009, Maliga and 
Bock, 2011). Until now, most studies focused on the expression of viral and bacterial vaccine 
antigens (Daniell et al., 2009, Bock and Warzecha, 2010, Cardi et al., 2010). Upon oral delivery, 
these vaccine antigens can trigger an immune response via the mucosa (Bienenstock and Befus, 
1980, Holmgren and Lycke, 1986) and adjuvants are used today to potentiate the response 
(Lycke and Holmgren, 1986, Holmgren and Czerkinsky, 2005). In contrast to a high number of 
reports focusing on the expression of antigens, there is a surprisingly limited number of reports 
on the plastid-based expression and subsequent application of other groups of therapeutics like 
small peptide drugs and human enzymes. Such therapeutic peptides / proteins ultimately need to 
enter the cytoplasm (pass the highly selective cell membrane barrier) to exert their action in the 
cytosol or organelles. Intracellular transport of membrane-impermeable biologically active 
molecules is one of the key problems in drug delivery (Torchilin, 2006). Although a first promising 
report about cellular delivery of plastid expressed proteins appeared in the field (Limaye et al., 
2006), the technology of cellular delivery is presently limited to the receptor-mediated route via 
adjuvants (Ruhlman et al., 2007, Verma et al., 2010, Boyhan and Daniell, 2011).  
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Despite the necessity to expand the advantages of plastid-based manufacture to new groups of 
therapeutics, modes of cellular delivery and intracellular targets for disease treatment,  
new carriers which offer the possibility for a receptor-independent passage across membranes, 
the highly selective brain-blood-barrier and even the human skin were not suggested. A field that 
offers extensive knowledge in this regard was established about twenty years ago with the 
discovery of cell penetrating peptides (CPPs). 
1.4 Cell penetrating peptides (CPPs) 
The concept of protein transduction into cells was first reviewed in 1968 by Ryser. Twenty years 
later, two independent groups reported the observation that the 86 AS HIV-1 transactivator 
protein Tat efficiently entered cells in vitro (Green and Loewenstein, 1988, Frankel and Pabo, 
1988). In a similar report in 1991, the group of Alain Prochiantz observed that the homeodomain 
of Antennapedia (a Drosophila transcription factor) was internalized by cells at conditions 
precluding endocytosis (Joliot et al., 1991). In 1994, Fawell et al. showed Tat-mediated 
transduction of covalently attached protein cargoes in vitro and in vivo – high molecular weight 
cargoes which would otherwise be excluded from cell entry. Vivès and co-workers (1997) mapped 
a minimal region responsible for Tat transduction, called Tat PTD (Protein transduction domain). 
PTDs are also referred to as cell penetrating peptides (CPPs). During this pioneering phase and the 
following years, a broad array of proteins that penetrate cells with and without an attached cargo 
were discovered and mapped to a minimal region (Prochiantz, 2000, Prochiantz, 2008).  
Short time after the discovery and study of structural properties of natural CPPs, artificial CPPs 
were designed. Today CPPs can be classified as naturally derived, chimeric or synthetic (Lindgren 
et al., 2000) and more than 100 sequences are known to be cell penetrating (Lindgren and Langel, 
2011). In the early years scientists were thrilled by the cellular drug delivery properties of CPPs 
since the therapeutic value of many new drugs is limited by their inability to cross the plasma 
membrane (Langel, 2002). The definition of CPPs is constantly evolving since their discovery. 
CPPs can be defined as short amphipathic or purely cationic peptides of less than 30 amino acids 
which possess a positive net charge, and which are able to penetrate biological membranes and 
transfer covalently or non-covalently attached bioactive cargoes into cells (Eiríksdóttir et al., 
2010). Once inside the cell, CPPs have been reported to accumulate in the nucleus (Bidwell et al., 
2009), but also mitochondria have been successfully targeted (Horton et al., 2008, Papadopoulou 
and Tsiftsoglou, 2011). The array and chemical nature of cargoes delivered by CPPs is impressive 
(Figure 2). 
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Figure 2. Schematic overview of possible applications where cell penetrating peptides have been shown to function 
well as delivery vehicles, both in vitro and in vivo. As presented in: Lindgren and Langel, 2011. 
1.5 Artefact discovery and CPP mechanism 
For the first decade data supported an energy-, temperature- and receptor-independent direct 
mechanism of cell entry for Tat and other CPPs (Langel, 2002). This independence of energy-
dependent endocytosis, however, was reported to be an artefact when it was discovered that cell 
fixation led to artificial CPP uptake (Lundberg and Johansson, 2001) and that the internalized 
amount of CPP was overestimated due to membrane bound peptide (Lundberg and Johansson, 
2002, Richard et al., 2003). In the following years a re-evaluation of CPP uptake started. 
Work on unfixed cells with inhibitors of endocytosis (to exclude endocytic uptake) and trypsin 
digest before FACS (to remove cell-bound CPPs), supported cellular uptake was due to different 
types of endocytosis (Fittipaldi et al., 2003, Wadia et al., 2004, Richard et al., 2005, Lundin et al., 
2008). Yet, studies still provided evidence for direct CPP penetration (Terrone et al., 2003, Thorén 
et al., 2003, Rothbard et al., 2004, Henriques et al., 2005, Deshayes et al., 2006, Fretz et al., 2007, 
Herce et al., 2009, Ter-Avetisyan et al., 2009, Watkins et al., 2009, Ciobanasu et al., 2010, Liu et 
al., 2011, Rydström et al., 2011, Hirose et al., 2012) and the discussions regarding the 
translocation mechanism are ongoing. Today it seems established that multiple transduction 
pathways are exploited in parallel by CPPs which depend on CPP concentration, size and nature of 
cargo, tested cell type and experimental setup (van den Berg and Dowdy 2011). 
Proposed pathways (Figure 3) for CPP transduction range from energy-independent direct 
penetration modes to energy-dependent endocytic modes (reviewed in: Madani et al., 2011, van 
den Berg and Dowdy, 2011). Historically, PTDs grouped under the name of CPPs are a very 
heterogenous group, which suggests that more than one single mechansim is involved. 
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It must be noted, however, that discussions about the mechansim are not only between but also 
within single CPPs. This is why the underlying mechansim of cell transduction of a given CPP-cargo 
complex needs to be investigated individually, and results from free CPPs cannot per se be 
extrapolated to their cargo-coupled counterparts (Holm et al., 2011). Recent reviews may serve as 
a source of further information (Magzoub and Gräslund, 2004, Ziegler et al., 2008, Järver, 2010, 
Walrant et al., 2012).  
A group of peptides with obvious structural and functional similarities to CPPs are antimicrobial 
peptides (AMPs) which are known for pore formation and / or lysis of target cells (Gunaratna et 
al., 2002, Henrigues et al., 2006). Some CPPs have been shown to act as antimicrobials 
(Nekhotiaeva et al., 2004). A recent review highlights the similarities between CPPs and AMPs 
(Splith and Neundorf, 2011). Lindgren and Langel (2011) mentioned in this regard that CPPs seem 
to have a position between antimicrobial peptides and peptides which use classical receptor-
mediated endocytosis for cell entry. However, neither of these peptides have shown such a 
potential for cargo and low-toxic delivery as CPPs (Lindgren and Langel, 2011). 
 
Figure 3. Suggested mechanisms of cell entry used by CPPs. Both energy-dependent and energy-independent 
mechanisms were shown to mediate CPP transduction. Endocytosis / Transcytosis are vesicle-based active processes 
(energy-dependent) of the internalization / redistribution of extracellular particles and fluids (Shen et al., 1992). 
Endocytosis can be further divided into sub-classes (for review: Doherty and McMahon, 2009) among which receptor-
independent macropinocytosis was increasingly shown to mediate the cell-entry of CPPs, especially in the transduction 
of large cargoes (Jones, 2007). Direct penetration mechanisms via e.g. the formation of a transient pore were reported 
to be most probable at high CPP concentrations and for primary amphipathic CPPs (see e.g. Madani et al., 2011) and do 
not require energy. Cell lysis as a result of energy-independent pore formation is suggested as mechanism for 
antimicrobial peptides which share similarities with CPPs in both sequence and degree of cell integrity disturbance 
(Splith and Neundorf, 2011). Schematic drawing modified from: Lindgen and Langel, 2011.  
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1.6 Clinical trials and future challenges 
Despite the ongoing discussions concerning the mechanism the concept of CPP-mediated delivery 
has proven successful with first phase II studies in 2003 (Rothbard et al., 2000, Chen and Harrison, 
2007). Over the years, CPP's versatile delivery potential was transferred to chemically diverse 
cargoes, targeting an impressive array of preclinical disease models (reviews documenting the 
drug field: Dietz and Bähr, 2004, Gupta et al., 2005, Patel et al., 2007, Foged and Nielsen, 2008, 
Heitz et al., 2009, Trabulo et al., 2010, Johnson et al., 2011). Today, over 20 phase I and phase II 
clinical trials are documented, none of which has reported adverse effects for patients (van den 
Berg and Dowdy, 2011). 
One strategy in the CPP field is the expression, purification and subsequent delivery of CPPs fused 
to therapeutic peptides / proteins. In 1999, a bacterial-expressed, fully-active 120 kDa 
ß-galactosidase was delivered in vivo to virtually every tissue of mouse including the brain 
(Schwarze et al., 1999). Since then, the CPP-mediated delivery of bioactive peptide / proteins was 
impressively expanded (reviews focusing on CPP fusion peptide / protein delivery: Dietz and Bähr, 
2005, Shi and Dowdy, 2007, Asoh and Ohta, 2008, Rapoport and Lorberboum-Galski, 2009, 
Johansson et al., 2011). 
In a recent work in CPP literature, attention is drawn to limitations in the current way of 
producing therapeutic CPP fusion peptides / proteins (Asoh and Ohta, 2008). Today, CPP fusion 
proteins are produced in bacterial cells, purified and then transduced to the disease model. 
The authors highlight limitations of the currently used bacterial system for the manufacture of 
CPP fusions, draw attention to endotoxin contamination and refer to unsolved problems with 
high-scale and low-cost purification. Until now, no alternative platform for the manufacture of 
CPP fusion proteins / peptides was suggested in the literature. 
1.7 Recently: Plants and CPPs 
Despite apparent mutual benefits for both research fields, the exchange of ideas, technology and 
the initiation of joint projects between scientists in the CPP sector and modern plant science is 
still at the beginning.  
One plant-derived CPP mentioned in the CPP literature (Prochiantz, 2000) is the maize homeobox 
transcription factor KNOTTED1 which was shown to pass plasmodesmata for cell-to-cell transport 
(Lucas et al., 1995, Kim et al., 2002). Tassetto et al. (2005) however, added a new aspect to the 
cell movement of KNOTTED1 with the observation of similarities between the cellular 
transduction of KNOTTED1 in plant and animal cells. Consequently, the third helix of KNOTTED1 
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showed the highest CPP properties, both with and without cargo when compared to the well-
studied CPPs Penetratin and (Arg)9 in a cell transduction study (Aussedat et al., 2006). Intercellular 
movement of transcription factors through plasmodesmata is today widely accepted (Wu and 
Gallagher, 2011).  
Besides the third helix of KNOTTED1 and members of the previously mentioned group of 
antimicrobial peptides (AMP members produced by the plants non-specific defense system; for 
review: Benko-Iseppon et al., 2010, Pelegrini et al., 2011) there is not much focus on the 
description of CPPs from plant origin. A recent publication suggests a new group of plant-derived 
CPPs, cyclic cell penetrating peptides, which are characterised by a cyclic cystine knot motif 
(Cascales et al., 2011). 
Recently, plant scientists started to elaborate the use of CPPs in their research (Roberts, 2005). 
In terms of CPP use for cargo delivery and manipulation of plant cells, the first study appeared in 
2004 (Rosenbluh et al., 2004). The group reported the successful delivery of Rhodamine and 66 
kDa BSA covalently attached to core histones into Petunia protoplasts. The authors refer to the 
artefact in the CPP field (see 1.5), provide evidence for direct translocation and clearly state that 
no endocytosis was involved.  
Since then reports appeared addressing the use of CPPs in plant science. Both, covalent and non-
covalent strategies were employed for the CPP-mediated delivery of different cargoes.  
Covalent strategies included the use of CPPs for the delivery of siRNA and silencing in tobacco 
suspension cells (Unnamalai et al., 2004) and the internalization of fluorescein into tobacco 
protoplasts (Mäe et al., 2005). CPP-GFP fusion protein was delivered to various root and 
epidermal explants (Chang et al., 2005). Fluorescent dye was delivered to Triticale protoplasts 
(Chugh and Eudes, 2007), to various Triticale explants and onion epidermal cells (Chugh and Eudes 
2008a) and to Triticale microspores (Chugh et al., 2009). The same group reported covalent 
(Chugh and Eudes, 2008b) and non-covalent (Chugh et al., 2009) delivery of GUS protein and 7.2 
kb linear plasmid encoding GUS to Triticale. Mizuno et al. (2009) delivered FDA labeled CPPs to 
tobacco suspension cells. It is interesting to note that the cell wall was not identified as a barrier 
in this study. 
Non-covalent strategies included the use of CPPs for the delivery of siRNA for gene silencing 
(Wang et al., 2007) and the delivery of fluorescent protein and ß-galactosidase to various explants 
(Wang et al., 2006, Chang et al., 2007). Transient GFP expression was achieved by the delivery of 
plasmid DNA (Chen et al., 2007). Hydrolase was delivered for the inhibition of seed germination 
 (Liu et al., 2007). Liu and co-workers (2008) tested fluorescent protein transduction in several 
organisms. CPP-mediated transduction was shown to work in archae bacteria, bacteria (both gram 
+ and gram -), cyanobacteria and yeast, but not in green algae and fungi. 
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While covalent delivery of GFP suggested an energy-independent direct pathway in plants (Chang 
et al., 2005), non-covalent studies suggested energy-dependent macropinocytosis (Chang et al., 
2007, Chen et al., 2007, Chugh et al., 2009).  
Combined covalent and non-covalent delivery and subsequent fluorescence resonance energy 
transfer (FRET) in onion epidermal cells suggested multiple endocytic internalization pathways 
 (Lu et al., 2010). Three reviews appeared in the field of CPPs and plants (Roberts, 2005, Eudes 
and Chugh, 2008, Chugh et al., 2010).  
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1.8 Aim of this thesis 
The present study aims at combining two exciting research areas which co-existed for more than 
20 years – the field of plastid transformation and the field of CPPs. 
 
The expression of CPP fusion proteins from the plastid attempts to answer the following 
questions: 
 
(1) CPPs were recently introduced to molecular plant science and some promising first reports in 
the field have emerged. However, there are no studies about the expression of CPPs in plants. 
This study addresses the following questions: Is it feasible to express fusions of nine classical CPPs 
to different proteins in plastids? What consequences do result for the plant? Are plants healthy, 
fertile, etc.? To which degree do CPP fusion proteins accumulate in the plant? Are there 
differences between the selected CPPs?  
 
(2) CPPs are reported to penetrate membranes by an array of suggested mechanisms.  
Today it seems established that CPPs with high molecular weight cargoes use endocytic 
transduction pathways (Edenhofer, 2008, Jones, 2010, Mäger et al., 2012), single studies, 
however, still report on direct modes (Hariton-Gazal et al., 2003, Rosenbluh et al., 2004, Chang et 
al., 2005, Cermenati et al., 2011). Which fusion protein localisation can be observed within the 
plant cell upon expression in the plastid? Are CPP fusion proteins restricted to the plastid or can 
any escape from the organelle to cytosol be observed?  
 
(3) Chances of CPP-mediated cellular delivery are currently evaluated in a number of phase I and II 
studies. Adverse effects are not reported so far (van den Berg and Dowdy, 2011). Recently, the 
search for alternative expression platforms for the manufacture of CPP fusion proteins was 
launched (Asoh and Ohta, 2008). Plants are a competitive platform for heterologous protein 
expression (Raskin et al., 2002, Koop et al., 2007, Paul and Ma, 2011). Can plastids be used for the 
expression of therapeutical CPP fusion proteins in a proof-of-principle study? 
 
 
 
 
2 Results 
The feasibility and benefits of CPP fusion protein expression in plastids was addressed in this 
study. Both basic science and applied aspects were tested. The approach was based on three 
plastid transformation vector series encoding for CPP fusions to three different proteins, stably 
expressed from the tobacco plastid genome:  
First, the enhanced green fluorescent protein (eGFP) vector series I (2.1) to track CPP fusion 
proteins by optical means, second, the production of anthocyanin pigment 1-Dominant (PAP1) 
vector series II (2.3) to provide a biological readout within the plant cell and, third, the 
phenylalanine hydroxylase (PAH) vector series III (2.4) to introduce the expression of CPP fusions 
to therapeutic proteins in plastids / plants. In section 2.2 the plastid transformation vector 
intermediate pUC18(C) is introduced which was used in the vector series II and III.  
2.1 eGFP vector series: tracking CPP fusion proteins 
As a starting point in the evaluation of CPP fusion protein expression in plastids, His-tagged CPP 
fusions with eGFP were expressed from the tobacco plastome. Such a system was supposed to 
fulfill two criteria:  
(1) eGFP fluorescence can be used as a convenient optical system to track CPP-eGFP fusion 
proteins upon expression in the plastid / plant.  
(2) CPP fusion proteins can be isolated via the His-tag for eGFP based transduction experiments 
into plant and animal cells.  
Nine prominent CPPs were selected for plastid transformation vector cloning (Table 1).  
 
Table 1. Selected CPPs, CPP abbreviation / number used in the text, origin, sequence and original publication.  
(1): Futaki et al., 2001, (2): Ho et al., 2001, (3): Vivès et al., 1997, (4): Joliot et al., 1991, (5): Soomets et al., 2000, (6): 
Morris et al., 2001, (7): El-Andaloussi et al., 2007, (8): Pooga et al., 1998, (9): Elliott and O’Hare, 1997. 
 
8x Arg  CPP1 synthetic RRRRRRRR (1) 
PTD-4 CPP2 synthetic, variant of CPP3 YARAAARQARA (2) 
Tat  CPP3 HIV-1 GRKKRRQRRRPPQ (3) 
Penetratin CPP4 Drosophila RQIKIWFQNRRMKWKK (4) 
Tp-10  CPP5 synthetic, variant of CPP8 AGYLLGKINLKALAALAKKIL (5) 
Pep-1  CPP6 synthetic KETWWETWWTEWSQPKKKRKV (6) 
M918 CPP7 synthetic MVTVLFRRLRIRRACGPPRVRV (7) 
Transportan CPP8 synthetic GWTLNSAGYLLGKINLKALAALAKKIL (8) 
VP22 CPP9 Herpes-Simplex Virus DAATATRGRSAASRPTERPRAPARSASRPRRPVE (9) 
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Cloning was performed with codon-optimized parts (adapted to the tobacco plastid codon usage) 
obtained by gene synthesis (GENEART). Ten expression cassettes were assembled in total and 
cloned into chloroplast transformation vector pKCZglpk (Scharff, 2002) to give rise to the eGFP 
vector series (Figure 4). 
 
 
Figure 4. Codon-optimized expression cassette for CPP fusion protein expression and transformation vector assembly 
of the eGFP vector series. (A) Elements and amino acid sequence of the His-tagged CPPx_eGFP in-frame fusion cassette. 
Principle cassette design according to Han et al., 2000 - GENEART condon optimized for the expression in tobacco 
plastids. His-tag: affinity tag for fusion protein purification, T: thrombin site, cppx: one out of nine CPPs (see Table 1.), 
egfp: eGFP, codon-optimized for plastid gene expression. A control cassette was assembled without CPP between Pst I 
and Xho I. (B) Assembly of nine CPPx_eGFP and one control_eGFP plastid transformation vectors. GENEART provided 
808 bp eGFP pre-cassette and 91 bp control pre-cassette were cloned via Nco I / Nhe I in working vector 
pPNG1014_MCS120 (Waheed et al., 2011). Single cppx coding regions were isolated from 100 bp fragments by 
digestion and were shotgun cloned via Pst I and Xho I upstream of egfp. Likewise, control cassette, 717 bp egfp was 
cloned in pPNG1014_MCS120_control via Xho I and Mlu I. Finally, the assembled ten expression cassettes were 
transferred via Xba I / EcoR V into tobacco transformation vector pKCZglpK (Scharff, 2002). pKCZglpK targets integration 
site trnN (INSL) / trnR (INSR) in the large inverted repeat (IR) (Zou et al., 2003). IRA: nucleotides 109,230–110,348 and 
110,349–111,520, IRB: nucleotides 131,106–132,277 and 132,278–133,396 tobacco plastome sequence according 
Yukawa et al., 2005.  
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The complete set of ten CPPx_eGFP vectors was transferred into tobacco leaves by the biolistic 
method. Leaves were cut two days post transformation and put on RMOP regeneration medium 
supplemented with 500 mg/l spectinomycin (Spec) as selective agent.  
Putative positive primary shoots were obtained for all vectors. No major differences were 
observed, however it should be noted that CPP7 yielded the highest number of transformants 
while CPP9 yielded the lowest. GFP positive shoots were identified by fluorescence microscopy. 
PCR analysis confirmed site-directed vector integration in the plastome with an internal / external 
primer pair (Figure 5). Cyclisation to achieve homoplasmy (compare Figure 1B) of positive 
transplastomic shoots continued until cycle V. At this stage, correct integration was further 
confirmed via Southern blot analysis (Figure 5).  
 
Figure 5. Identification of transplastomic CPPx_eGFP lines and confirmation of correct vector integration into the 
plastome by PCR and Southern blot. (A) Schematic drawing of eGFP transformation vector, WT plastome and 
transplastomic plastomes after homologous transformation vector integration. Primers for PCR are indicated with 
arrows. External primer (binds to the plastome): red; internal primer (binds to vector element): black. 
For Southern blot, BamH I cutting sites and probe location are given. (B) PCR with external primer LF fwd and internal 
primer GFP rev amplified a 3078 bp mutant fragment in the transplastomic lines but not in WT. (C) Southern blotting 
confirmed site-directed integration in the plastome and indicated homoplasmy by the detection of the mutant 
fragment and the absence of the WT fragment in the transplastomic lines. 2 µg of DNA was digested with BamH I and 
hybridized with a 325 bp probe which was amplified with primers Probe new CPP fwd / Probe new CPP rev. Expected 
fragment sizes: WT: 7063 bp, mutant 2888 bp. WT: wild-type, c: control_eGFP line, numbers 1 to 9: CPPx_eGFP lines, 
according to the CPP abbreviation code introduced in Table 1. 
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Homoplastomic lines were grown to maturity in the greenhouse and the plants’ ability of self-
pollinating and to develop seeds was monitored. When lines were allowed to self-pollinate, eight 
from ten lines produced viable seeds. Self-pollination in the case of line CPP7_eGFP led to tiny 
capsules (Figure 6) with degenerated, infertile seeds. Self-pollinating in the case of line 
CPP9_eGFP did not lead to any fertilization event at all.  
These results were confirmed using a reciprocal cross approach (Figure 6A). All line-♀ x WT-♂ 
crosses were successful and resulted in viable seeds. WT-♀ x CPP7_eGFP-♂ resulted in a tiny 
capsule. Accordingly, the cross WT-♀ x CPP9_eGFP-♂ was unsuccessful. 
To further confirm homoplasmy indicated by Southern blot (Figure 5), seeds originating from the 
reciprocal crosses were germinated on B5Spec (Figure 6). Seedlings originating from a cross lines-♀ 
x WT-♂ exhibited a green phenotype confirming that plastids in the progenies were of maternal 
origin and only contained the mutant plastome. Accordingly, when a WT-♀ was crossed with the 
lines-♂, all resulting seedlings showed a pale white phenotype on B5Spec. This further confirmed 
that no plastids were spread by pollen and all plastids inherited by the mother were of WT origin. 
 
Figure 6. Crossing experiments with the CPPx_eGFP lines. (A) Handling of lines for reciprocal crossing (modified from 
Herrera-Diaz, 2011). (B) Tobacco WT capsule in comparison to a capsule originating from a fertilization event with 
CPP7_eGFP line pollen. (C) Germination of seeds originating from reciprocal crosses: WT-♀ x CPP1_eGFP-♂ (1) on B5 (2) 
on B5Spec, CPP1_eGFP-♀ x WT-♂ (3) on B5 (4) on B5Spec – one exemplary result is shown. 
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To determine fusion protein localisation in seed-grown homoplastomic plants, early division 
stages of protoplast-derived cells embedded in alginate were studied at CLSM. CLSM provided 
exciting insights in the highly dynamic network of stromules within dividing protoplasts. However, 
no fundamental differences between the CPPx-eGFP fusion proteins were observed (Figure 7). 
Stromules (stroma-ﬁlled tubules) are tubular extensions of the plastid envelope (Köhler and 
Hanson 2000). They occur in all types of plastids and are connected to actin mircofilament
 
Figure 7. First division stages of CPPx_eGFP protoplast-derived cells. CPPx-fusion protein was contained in the plastid-
stromule-network. Stromules, long extensions originating from the plastid envelope, were detected in all lines.  
Note, that these must not be mistaken for cytosolic components. Characteristic differences accounting for single CPPs 
were not identified. Detection of stromules was correlated with the degree of CPPx-eGFP fusion protein accumulation. 
Arrows: stromules. WT: wild-type, c: control_eGFP line protoplast-derived cell, numbers 1 to 9: CPPx_eGFP lines 
protoplast-derived cells. CLSM was performed with a Leica TCS-SP2. Scale bar: 20 µm. 
 
bundles which are responsible for their dynamics (Kwok and Hanson, 2003, Natesan et al., 2005). 
Stromules were repeatedly described in the literature in the last 100 years (Gray et al., 2001) and 
were rediscovered only 15 years ago with the advent of GFP (Köhler et al., 1997). Their role is not 
fully understood but the transport of proteins as large as RubisCO (550 kDa) has been shown 
(Kwok and Hanson 2004). Mitochondria, the ER and the nucleus have been reported to be 
associated (Schattat et al., 2011 and references therein). Stromules greatly extend the surface of 
the plastid network, which suggests a role in communication / import / export with the cytosol 
(Natesan et al., 2005, Hanson and Sattarzadeh, 2008, Hanson and Sattarzadeh, 2011).  
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Recently, plastid DNA and ribosomes were shown not to travel through stromules which suggests 
that the exchange of genetic information via this route is not common (Newell et al., 2012). 
Work with the CPPx-eGFP system was repeatedly challenged by artefacts displaying cytosolic 
fusion protein localisation. Initially, water-infiltrated leaves were studied. Water-infiltration 
however turned out to cause damage to the leaf tissue, which resulted in fusion protein release to 
the cytoplasm (Figure 8A). Accordingly, when scalpel cutting edges were studied, only cells in 
proximity to the cutting edge revealed cytosolic fusion protein localisation (Figure 8B). Even the 
most sensitive method to assess fusion protein localisation, the cultivation of protoplast-derived 
cells, yielded low frequencies of cells with CPPx-eGFP fusion protein in the cytosol (Figure 8C).  
In this regard it is important to note that in homoplasmic tissues the localisation of plastid- 
 
Figure 8. Ease of artefact generation as a drawback of the CPPx-eGFP system. (A) Water-infiltration in leaves can 
disrupt the integrity of the cells which results in CPPx-eGFP fusion protein release from the plastid to the cytoplasm – 
shown here: CPP6_eGFP. Fusion protein is distributed over the cytoplasm of all cells in the tissue. Scale bar: 25 µM. 
(B) Scalpel cutting edges reveal the effect of disruptive methods on CPPx-eGFP fusion protein localisation within the 
plant tissues. Dashed line: cutting edge of CPP4_eGFP leaf. Cells in proximity of the cutting edge are filled with fusion 
protein which was released from the plastids. Scale bar: 25 µM. (C) Cytosolic fusion protein localisation as a rare event 
of studying dividing protoplast-derived cells – CPP7_eGFP. Fusion protein which is released from the plastids (P) stains 
the cytoplasm (arrows) which is distributed to border regions in the cell by vacuolar elements (VE). Scale bar 10 µm.  
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expressed proteins should be identical. Cytosolic localisation in only a small fraction (less than 5%) 
of the cells is therefor probably due to leakage from plastids caused by mechanical damage during 
sample preparation. Challenged by these limitations and taken into account that small scale 
escape from the plastid may not be detectable by visual means at all, we decided to highlight a 
potential escape scenario from the plastid with a second, highly sensitive physiological system. 
This system is described in section 2.4. 
The degree of fusion protein accumulation in the transplastomic CPPx_eGFP lines was 
determined. Total soluble protein (TSP) of mature plants before flowering was extracted and 
quantified by the Bradford assay. Ten µg of TSP were separated by SDS-PAGE. Only in the case of 
CPP7_eGFP a faint band of the expected ~ 30 kDa was detected (Figure 9). 
 
Figure 9. Adult stages of CPPx_eGFP lines and SDS-PAGE of extracted total soluble protein (TSP). (A) TSP was extracted 
from seed-grown CPPx_eGFP lines before flowering. WT: wild-type, c: control_eGFP line, numbers: CPPx-eGFP lines. 
(B) Separation of 10 µg TSP by 10% SDS-PAGE. Faint band of CPP7-eGFP accumulation is marked with a star.  
Defined amounts of BSA were loaded for comparison. WT: wild-type, c: control_eGFP line, numbers: CPPx_eGFP lines, 
LSU: RubisCO large subunit, SSU: RubisCO small subunit. 
26 Results 
 
 
To perform CPP fusion protein transduction assays into protoplasts and human cells, CPPx-eGFP 
fusion proteins were isolated from the transplastomic plants via the His-tag. Some fusion proteins 
(CPP1-eGFP, CPP3-eGFP, CPP7-eGFP) in the plant extracts, however, did not bind to the 
Ni2+-agarose (Biontex). To selectively isolate fusion proteins from the plants, the isolation strategy 
was switched to Hi-Trap Butyl HP columns (GE Healthcare). Only in the case of CPP7-eGFP 
(compare Figure 9), the enriched band was clearly visible in the SDS-gel (Figure 10). 
 
Figure 10. HIC purified CPPx-eGFP fusion proteins separated on SDS-PAGE. 15 µl each were loaded. Amount of CPP7-
eGFP was estimated 3 µg, which equals 1.7 mg fusion protein per ~40 g of FW. c: control-eGFP line, numbers 1 to 9: 
CPPx-eGFP lines. Enriched band of CPP7-eGFP protein is marked with a star. LSU: RubisCO large subunit. 
 
Due to the low accumulation levels of CPPx-eGFP fusion proteins in the plastids, fusion proteins 
were isolated from the E. coli XL1 blue cells used for cloning (6.2.8.4). In six out of ten cases, there 
was detectable expression judged from GFP fluorescence of the harvested bacterial cell pellets. 
Purification was carried out with Ni2+-agarose and / or HIC columns according to the 
manufacturer's suggestions. Samples were dialyzed against 50 mM Tris-HCl pH 8.0 at 4 °C, 
adjusted to 10% glycerol, quantified by the Bradford assay and stored at - 80 °C until the analysis. 
 
Fusion proteins purified from E. coli or plants (CPP7-eGFP) were used for transduction 
experiments into freshly isolated protoplasts and partially digested young leaf tissue (6.2.9.1). 
Incubations were carried out at fusion protein concentrations from 1-5 µM for one hour (Figure 
11) and 5 µM for 24 hours (Figure 12). However, no fusion protein internalization was observed 
under these conditions.  
 
 
USE THE SCANNED PICS 
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Figure 11. Transduction of CPPx-eGFP fusion proteins into tobacco WT protoplasts. Freshly isolated protoplasts were 
incubated with 1-5 µM CPPx-eGFP fusion protein for 1 h. Gain for GFP fluorescence was normalised to zero with the 
help of WT protoplasts before studying the eGFP signal after incubation with cPPx-eGFP fusion protein. No differences 
were revealed. For cytoplasmatic localisation compare Figure 8. Left row: bright field and chlorophyll autofluorescence 
overlay, Right row: GFP fluorescence recorded from protoplasts after incubation with CPPx-eGFP fusion protein. 
+: stands for fusion protein addition to WT protoplasts, c: control-eGFP fusion protein, numbers: CPPx-eGFP fusion 
proteins. Scale bar: 10 µm. 
 
In addition to this experimental setup, fusion proteins were heat denatured (95 °C for 10 min), 
since it has been stressed that denaturation might facilitate the transduction of CPPs into cells 
(Nagahara et al., 1998). However, heat denaturation did not alter the outcome of the experiments 
(data not shown). It was later recognized that denaturation is not a prerequisite for transduction 
(Han et al., 2000, Caron et al., 2001). 
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Figure 12. Transduction of CPPx-eGFP fusion proteins into partially digested young WT tissues. Partially digested 
young tissues were incubated with 5 µM CPPx-eGFP fusion protein for 24 h. Gain for GFP fluorescence was normalised 
to zero with the help of WT tissue before studying the eGFP signal after incubation. No differences were observed. 
For cytoplasmatic localisation compare Figure 8. Upper row: bright field and chlorophyll autofluorescence overlay, 
Lower row: GFP fluorescence recorded after incubation with CPPx-eGFP fusion protein. Ø: untreated WT protoplasts, 
+: stands for fusion protein addition to WT protoplasts, c: control-eGFP fusion protein, numbers: CPPx-eGFP fusion 
proteins. Scale bar: 50 µm. Scale bar for Ø: 70 µm.  
 
After CPPx-eGFP fusion proteins failed to penetrate plant cells, we were interested, if the isolated 
fusion proteins were able to penetrate human cells. Three cell lines were selected for 
transduction experiments: Jurkat T cells (suspension), HeLa cells (adherent) and Phoenix cells 
(adherent). Transduction was tested in a range of CPPx-eGFP fusion protein concentrations from 1 
to 10 µM with incubation times from 30 min to 24 h at 37 °C.  
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To avoid artefacts, cells were trypsinized and quenched prior to FACS analysis. Interestingly, 
experiments could not detect differences between untreated, control-eGFP-treated and CPPx-
eGFP-treated human cells. The result of a characteristic experiment is shown in Figure 13.  
 
Figure 13. Transduction of CPPx-eGFP fusion proteins into human cells (FACS analysis). The read-out of the 
transduction of one exemplary CPPx-eGFP fusion protein (CPP3-eGFP = Tat-eGFP) in two cell lines is presented  
(fusion protein concentration in the experiment: 10 µM). FACS revealed an increase in GFP fluorescence in both the 
control-eGFP and the CPPx-eGFP-treated cells. Adherent Pheonix cells: (A) 1 h of incubation. (B) 24 h of incubation. 
Jurkat T suspension cells: (C) 1 h of incubation. (D) 24 h of incubation. HeLa cells were tested separately and gave 
comparable results (not shown). 
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2.2 Plastid transformation vector intermediate pUC18(C) 
Low fusion protein accumulation was observed in the transplastomic lines of vector series I (2.1). 
To potentially increase the protein yield in the plastids, a new plastid transformation vector 
intermediate was cloned (Figure 14). The same regulatory elements were used as with the  
vector series I, but a new insertion site was targeted, namely the trnfM / trnG insertion site  
(Ruf et al., 2001).  
Increased expression strength was considered desirable, since modes of CPP penetration were 
reported to be associated with CPP concentration (Duchardt et al., 2007, Kosuge et al., 2008). 
Increased protein accumulation in the plastid and a resulting high protein pressure might favour a 
switch to a direct penetration mode and a subsequent transfer of CPP fusion protein from the 
plastid to the cytosol (vecort series II, 2.3). Besides this aspect, for a biotechnological production 
of therapeutic CPP fusion proteins in plastids, high protein yields are mandatory (vector series III, 
2.4). 
 
Figure 14. Cloning the transformation vector intermediate pUC18_IN*_CPP cassette_rbcL (= pUC18(C)), targeting 
insertion site trnfM / trnG. A 3637 kb INS* fragment was amplified from the tobacco plastome as part of a larger 
fragment (Primer INS**fwd / INS**rev) and was inserted via Pst I / Kpn I (Pst I (36840) and Kpn I (40481), restriction 
enzyme site locations in the tobacco plastome, Yukawa et al., 2005)) into pUC18 resulting in pUC18_INS*. 
CPP expression cassette with promoter and 5´regulatory elements was amplified from the eGFP vector series 
(Primer KNT1 fwd / KNT1 rev) and transferred into the Spe I site (38316, location in tobacco plastome) in pUC18_ INS*, 
resulting in pUC18_INS*_CPP cassette. Finally, TrbcL 3’ (Primer rbcL fwd / rbcL rev) was inserted downstream of the CPP 
cassette via Nhe I and Afl III to give rise to pUC18_INS*_CPP cassette_rbcL (=pUC18(C)). Transformation vector 
intermediate pUC18(C) allows the convenient exchange of CPPx and Goi. It further allows the insertion of the aadA 
gene in the vector backbone for antibiotics selection marker removal according to Klaus et al., 2004. 
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2.3 PAP1 vector series: providing a physiological CPP read-out 
To overcome the artefact susceptibility of the fluorescence based eGFP system (see 2.1) and to 
increase the overall detection sensitivity, we were interested in a system which could provide a 
physiological read-out induced by a potential CPP-mediated fusion protein transfer from the 
plastid to the cytosol. Preferably such biological read-out could be detected by easy means 
without any processing of the plant.  
The purple Arabidopsis thaliana mutant Production of anthocyanin pigment 1-Dominant (pap1-D) 
was identified by screening activation-tagged lines (Borevitz et al., 2000). The underlying 
phenotype is caused by overexpression of a gene encoding MYB transcription factor PAP1. 
When PAP1 was overexpressed in tobacco, PAP1 activated the anthocyanin pathway which 
resulted in massive production of anthocyanins throughout the plant but no other morphological 
phenotype (Borevitz et al., 2000, Xie et al., 2006). Such dominant phenotypic readout was 
regarded suitable to test for CPP-mediated escape from the plastid. The following system was 
proposed (Figure 15). 
 
Figure 15. Proposed action of CPPx-PAP1 fusion proteins upon their production in the plastid. In a first step, 
the CPPx-PAP1 fusion protein is translocated to the cytoplasm via CPP-mediated transfer from the plastid to the cytosol.  
This is followed by nuclear targeting sequence-mediated import into the nucleus. PAP1 activation of anthocyanin 
biosynthesis results in a high anthocyanin phenotype of the transplastomic plant. T: transformation vector delivery of 
the CPPx_PAP1 series. 
 
Agrobacterium harboring PAP1 transformation vector pSB419 (Sharma and Dixon, 2005) was a 
kind gift of Richard Dixon. Leave disc transformation (Horsch et al., 1985) was carried out to 
generate a positive control (nuclear transformant) for the approach. 
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Regeneration of nuclear transformants started from bleached leaf pieces with a purple callus 
which subsequently gave rise to pap1 shoots (Figure 16). Pap1 transformants were grown to 
maturity and allowed to self-pollinate in the greenhouse. Crossing was carried out until T2 
generation. 
 
Figure 16. Generation and phenotype of nuclear transformant pap1. Top left corner: high anthocyanin callus as the 
result of Agrobacterium tumefaciens-mediated tobacco leaf disc transformation with transformation vector pSB419. 
Other pictures: anthocyanin accumulation in pap1 compared to WT, pap1 left, WT right side. 
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For stable transformation of the plastid genome, transformation vectors encoding fusion proteins 
of all nine CPPs with PAP1 and one control vector without CPP were cloned (Figure 17). Vector 
cloning was based on transformation vector intermediate pUC18 (C) introduced in 2.2 (Figure 14).  
 
Figure 17. Cloning of the PAP1 transformation vector series. Briefly, the 747 bp PAP1 coding region was amplified 
(primer: Pap1 fwd / Pap1 rev) from Agrobacterium transformation vector pSB419 (Sharma and Dixon, 2005) and cloned 
via Xho I and Nhe I sites into pUC18_INS*_CPP cassette_rbcL (see 2.2, Figure 14). Next, the dicistronic operon was 
restored by exchanging TrbcL with aadA_TrbcL via Nhe I / Not I transfer from the eGFP vector series (see 2.1, Figure 4). 
Finally, cppx parts were exchanged via Sac II and Xho I to give rise to the PAP1 plastid transformation vector series. 
 
The full set of CPPx_PAP1 vectors was transformed into tobacco by the biolistic method. 
Transformation yielded transplastomic plants for all constructs, however, despite repeated 
transformations attempts, no transplastomic line for transformation vector CPP5_PAP1 was 
recovered. Positive lines were identified by PCR (Figure 18) and cyclization was carried out until 
cycle II to IV. No enhanced anthocyanin phenotype was observed. In contrast, upon shoot 
formation, lines showed a pale-green chlorotic phenotype. Southern blot analysis confirmed 
correct integration and indicated homoplasmy state for all lines except for CPP8_PAP1 (Figure 18).  
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Figure 18. Identification of transplastomic CPPx_PAP1 lines and confirmation of correct vector integration into the 
plastome by PCR and Southern blot. (A) Schematic drawing of PAP1 transformation vector, WT plastome and 
transplastomic plastomes. Primers for PCR are indicated with arrows. External primer (binds to the plastome): red; 
internal primer (binds to vector element): black. For Southern blot, Hind III cutting sites and probe location are given. 
(B) PCR with external primer INS**fwd and internal primer PAP1 proof rev amplified a 3719 bp mutant fragment in the 
transplastomic lines but not in WT. (C) Southern blotting confirmed site-directed integration in the plastome and 
indicated homoplasmy by the detection of the mutant fragment and the absence of the WT fragment in the 
transplastomic lines. 2 µg of DNA was digested with Hind III and hybridized with a 376 bp probe which was amplified 
with primers Probe v2 fwd / Probe v2 rev. Expected fragment sizes: WT: 4494 bp, mutant: 3120 bp. Line CPP8_PAP1 did 
show WT fragment. WT: wild-type, c°: control_PAP1 line, numbers 1° to 9°: CPPx_PAP1 lines.  
 
Plants were transferred to the greenhouse for seed production. Growth under greenhouse 
conditions did not suggest elevated anthocyanin contents (Figure 19). This was further confirmed 
by thin-layer chromatography analysis of anthocyanin contents in leaves of greenhouse-grown 
plants (not shown). All lines in the greenhouse were capable of self-pollination except for line 7°. 
Line 8° and line 9° developed less and smaller capsules. Seeds obtained from pollinations with WT 
were surface sterilized and sown on B5Spec to check seed-grown phenotype plants (not shown).  
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Figure 19. Phenotype of transplastomic PAP1 lines in comparison to pap1 nuclear transformant. PAP1 lines were 
regenerated from tissue culture and Southern blot confirmed homoplasmy. In T1 grown from seeds, the chlorotic 
phenotype was established however the growth size phenotype was less pronounced. c°: control_PAP1 line, numbers 
1° to 9°: CPPx_PAP1 lines, pap1: nuclear transformant (positive control).  
 
To determine whether the observed chlorotic phenotype was due to high protein accumulation 
levels in the lines, TSP was extracted and separated by SDS-PAGE. No prominent band resulting 
from CPPx-PAP1 fusion protein accumulation was observed. Chlorosis, however, exhibited an 
effect on the amount of RubisCO large subunit (Figure 20). 
 
Figure 20. SDS-PAGE of extracted CPPx_PAP1 soluble protein (TSP). 10 µg TSP were separated, defined amounts of 
BSA were loaded for comparison. WT: wild-type, pap1: pap1 nuclear transformant, c°: control_PAP1 line, numbers 1° to 
9°: CPPx_PAP1 lines. LSU: RubisCO large subunit, SSU: RubisCO small subunit. 
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2.4 PAH vectors series: CPP fusions for the clinic 
To date, CPP fusion proteins / peptides are expressed in bacterial cells, alternative expression 
systems are missing (Asoh and Ohta, 2008). To introduce the expression of CPP fusions of clinical 
value in plants, we aimed to express CPP fusions to a human enzyme from the plastid. Such a 
plastid-expressed fusion protein could be used for the substitution of a non-functional protein in 
the human body. Approaches like this are termed enzyme replacement therapy (ERT) (Fratantoni 
et al., 1968, Neufeld, 2006). ERT is a promising field of disease treatment, especially in the 
treatment of lysosomal storage diseases (Brady 2006, Goldblatt et al., 2011). ERT is challenged by 
high costs for the development and subsequent production of the enzyme in question 
(Wraight, 2006). In 2007, studies have shown the feasibility of plant-based production of 
glucocerebrosidase for the ERT of Gaucher's disease (Shaaltiel et al., 2007, Aviezer et al., 2009) 
and today plant-based production of pharmaceuticals has proven successful in several clinical 
trials (for review: Paul and Ma, 2011).  
Only recently, CPPs have entered the field of ERT with great success (Rapoport and  Lorberboum-
Galski, 2009). CPP-mediated ERT in the case of phenylketonuria (PKU) (Eavri and Lorberboum-
Galski, 2007) is considered a very promising approach in the treatment of the disease (Sarkissian 
et al., 2009). PKU is the most frequent inborn genetic disorder of amino acid catabolism (Online 
Mendelian Inheritance in Man 261600). It is characterised by the body´s inability to convert food 
supplied phenylalanine (Phe) to tyrosine, caused by deﬁciency of phenylalanine hydroxylase 
(PAH). If untreated, resulting Phe accumulation leads to impaired postnatal development. PKUs 
classical treatment includes a life-time vegan diet / dietary protein restriction combined with the 
supplementation of tyrosine. BH4 supplementation, PAHs natural co-factor, was identified as an 
effective treatment for mild forms of PKU (Muntau et al., 2002). This led to the first commercial 
product on the market: Kuvan® (sapropterin dihydrochloride), the synthetic form of BH4. 
Kuvan® is today widely applied, its effect, however, is limited in some genotypes and its chemical 
synthesis is very expensive (Santos-Sierra et al., 2012).  
Given the great promise of CPP-PAH fusions for the treatment of PKU, the diseases clear 
connection to food and the classical dietary way of treatment, PKU was selected for the proof-of-
principle analysis of plastid expressed CPP fusions for the clinic.  
Besides the CPP Tat (= CPP3) which was used by Eavri and Lorberboum-Galski (2007), synthetic 
Tat variant PTD-4 (= CPP2) was chosen since PTD-4 showed 43-times the transduction ability when 
compared with native Tat (Ho et al., 2001). 
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Transformation vector cloning was based on the transformation vector intermediate pUC18(C), 
which targets the trnfM / trnG insertion site in the plastid genome (see 2.2, Figure 14). Pah ORF 
for cloning was a kind gift of Ania Muntau (Dr. von Hauner Children’s Hospital, LMU Munich).  
Two vector categories were generated (Figure 21). One with the aadA gene (antibiotics selection 
marker) between the homologous insertion flanks for conventional stable resistance marker 
integration and one with aadA cassette in the vector backbone for cointegrate formation and 
subsequent antibiotics resistance marker removal (Klaus et al., 2004). 
 
Figure 21. Cloning of the PAH transformation vector series. (A) Cloning of the PAH transformation vector with aadA 
gene between the homologous insertion flanks for conventional resistance marker integration. First, the dicistronic 
operon was restored in pUC18_INS*_CPP cassette_rbcL (see 2.2, Figure 14) by exchanging TrbcL with aadA_rbcL via 
Nhe I / Not I transfer from eGFP vector series (see 2.1, Figure 4). Next, cppx parts were exchanged to cpp2, cpp3 and 
control via   Sac II and Xho I. Finally, 1360 bp pah was inserted via Xho I / Nhe I into all three constructs to get final 
plastid transformation vectors. (B) Cloning of the PAH transformation vector with aadA cassette in vector backbone. 
Sac II / Nhe I part from pUC18_INS*_CPP cassette_rbcL_PAP1_aadA_extern (unpublished, aadA cassette was inserted in 
the Sca I site, position: 2108, in pUC18 vector backbone) was exchanged with Sac II / Nhe I part from the PAH 
transformation vector series with the aadA gene between the homologous insertion flanks (see Figure 21 A). 
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Vectors of the CPPx_PAH series were transformed into tobacco plastids by the biolistic method. 
Plants were regenerated for both vector categories. Despite several transformation attempts, no 
transplastomic plant was identified for the control transformation vector.  
This happened to be the case for both the construct with aadA in the vector backbone and for the 
one with aadA between the homologous insertion flanks. For CPP2 and CPP3, however, PCR and 
Southern blotting identified and confirmed successful transformation events. One plant per 
category was studied in greater detail (Figure 22). 
 
Figure 22. Identification of transplastomic CPPx_PAH lines and confirmation of correct vector integration into the 
plastome by PCR and Southern blot. (A) Schematic drawing of PAH transformation vector (internal aadA), WT plastome 
and transplastomic plastomes. Primers for PCR are indicated with arrows. External primer (binds to the plastome): red; 
internal primer (binds to vector element): black. For Southern blot, Hind III cutting sites and probe location are given. 
Note: PAH transformation vector (external aadA) is also presented. PCR and Southern blot for this construct resulted in 
the same fragment sizes as for the PAH transformation vector with internal aadA. (B) PCR with external primer 
INS**fwd and internal PAH Nhe I rev amplified a 4410 bp mutant fragment in the transplastomic lines but not in WT.  
(C) Southern blotting confirmed site-directed integration in the plastome and indicated homoplasmy by the detection of 
the mutant fragment and the absence of the WT fragment in the transplastomic lines. 2 µg DNA was digested with Hind 
III and hybridized with a 376 bp probe which was amplified with primers Probe v2 fwd / Probe v2 rev. 
Expected fragment sizes: WT: 4494 bp, mutant: 3120 bp. WT: wild-type, 2*: CPP2_PAH (external aadA) line, 
3*: CPP3_PAH (internal aadA) line.  
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Regenerated CPP2_PAH (internal aadA) line showed a normal growth phenotype and faintly 
chlorotic leaves. CPP3-PAH (external aadA) in contrast had thick leaves combined with severe 
stunted growth and difficulties in root production (Figure 23). CPP2_PAH plant was rooted and 
transferred to the greenhouse. To check for protein accumulation in the lines, total soluble 
protein was extracted from the homoplasmic lines and separated by SDS-PAGE (Figure 23).  
 
Figure 23. Phenotype of CPPx_PAH lines and TSP separated by SDS-PAGE. (A) Phenotype of CPPx_PAH lines. 
2*: CPP2_PAH (external aadA) line, 3*: CPP3_PAH (internal aadA) line. (B) 10 µg of TSP were separated by SDS-PAGE. 
No CPPx-PAH fusion protein accumulation was observed. LSU: RubisCO large subunit, SSU: RubisCO small subunit. 
 
Seeds of line CPP2_PAH were obtained by self-pollination in the greenhouse. When CPP2_PAH 
(external aadA) seeds of T1 generation were germinated on B5 and B5spec medium, pale white 
seedlings occurred in presence of the antibiotics (Figure 24). This indicated the loss of the 
antibiotics marker aadA by loop-out recombination as suggested by Klaus et al., 2004. 
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Figure 24. Germination of CPP2_PAH (external aadA) T1 seeds on B5 (left jar) and on B5Spec (right jar). Loss of the 
antibiotics resistance gene aadA resulted in pale white seedlings on media with antibiotics. 
To test plastid-manufactured CPP2-PAH fusion proteins in the clinic, CPP2-PAH fusion proteins 
were isolated from CPP2_PAH (external aadA) crude plant extract via FPLC and gel filtration. 
However, when fusion protein accumulation was assayed by Western blot, no CPP2-PAH fusion 
protein was detected in the analysed samples (Figure 25). 
 
Figure 25. Gel filtration and identification of CPP2-PAH fusion protein by Western blot. (A) Gel filtration profile 
revealed two peaks (B1-B5, D8-D4) and one degraded fraction (E11-G09). (B) Western blot identification of CPP2-PAH 
fusion protein in different fractions. In the positive control only, PAH was detected. 1: crude plant extract, 2: pooled 
fractions after FPLC (Ni
2+
-affinity chromatography via His-tag), 3: fraction B1-B5 (gel filtration), 4: fraction D8-D4 
(gel filtration), 5: control (PAH purified from E. coli). Analyses were performed by Dunja Reiß at Dr. von Hauner 
Children’s Hospital, LMU Munich. 
3 Discussion 
This study was designed in view of the high number of reports about the expression of vaccine 
antigens and the comparably limited number of studies on the expression of other therapeutic 
peptides / proteins in plastids. Today, many promising therapeutics are limited in their clinical 
application due to limitations in their cellular delivery. Size and chemical nature of these drug 
candidates do not allow free diffusion across the plasma membrane and consequently demand a 
suitable carrier system. A group of versatile carrier peptides mediating cellular delivery are cell 
penetrating peptides (CPPs). Despite a long history of uncertainties concerning the exact CPP 
mechanism, clinical trials of CPP-mediated cellular delivery were launched only short time after 
CPP discovery. To date, CPP fusions for the clinic are prepared from bacterial cells with associated 
bottlenecks like endotoxin contamination, scale up etc. From the perspective of scientists working 
in the CPP field (Asoh and Otha, 2008), alternative expression platforms are highly desirable.  
To date, no reports about the expression of CPP fusion proteins in plants have emerged in the 
literature. This study aimed to fill this gap. Three approaches were employed in a proof-of-
principle study.  
First, the general feasibility of CPP fusion protein expression in the plant was assessed. Second, it 
was addressed which fusion protein localisation results upon expression in the plastid. Third, it 
was asked whether plastids can be used for the expression of therapeutical CPP fusion proteins in 
a proof-of-principle study. 
The results of this study suggest that the production of CPP fusion proteins is feasible in general. 
Leakage of CPP fusion protein from the plastid was not observed. The clinical proof-of-principle 
was not conducted due to low CPP fusion protein expression levels. Limitations of the current 
study are identified and discussed to provide a framework for further approaches.  
3.1 Expression of CPP fusion proteins in tobacco plastids is 
feasible 
Twenty transplastomic lines were established in this work, expressing an array of cell penetrating 
peptide fusions to proteins in the tobacco plastid. Up to nine different CPPs were fused to the 
fluorescent protein eGFP (vector series I, see 2.1), the transcription factor of anthocyanin 
biosynthesis PAP1 (vector series II, see 2.3) and the human enzyme of phenylalanine metabolism 
PAH (vector series III, see 2.4).  
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CPP fusion proteins have never been expressed in the plastid / plant before. Judging from the 
experiences made in this study, the expression of CPP fusion proteins in the organelle is feasible. 
Transplastomic plants reached homoplasmy, produced viable seeds and stably inherited the 
desired trait to their progenies in a maternal fashion. Transplastomic plants also provided an 
insight into pleiotropic effects, which can result from the expression of heterologous proteins in 
plastids (reviewed in Ruiz and Daniell, 2005, Lössl and Waheed, 2011). 
A chlorotic phenotype was observed in some CPP_PAP1 lines (Figure 19). This phenotype was also 
reflected by the lower amount of RubisCO large subunit detected by SDS-PAGE (Figure 20). 
In addition to chlorosis, small growth occurred in this vector series. Severe stunted growth was 
observed in the case of CPP3_PAH (Figure 23). In this line, the observed dwarf phenotype was 
combined with impaired root development and late flowering (not shown). Reproducible traits, 
like male sterility and reduced seed capsule size were observed in both eGFP and PAP1 vector 
series. No plant was regenerated for CPP5_PAP1. No plant could also be regenerated for the 
control construct of the PAH vector series.   
For all lines SDS-PAGE revealed low levels of fusion protein accumulation in adult plants. 
This suggests that the mentioned phenotypic effects are rather a consequence of the nature of 
the CPP fusion protein itself than of the high degree of fusion protein accumulation. 
As introduced by Tregoning et al. (2003), high amounts of accumulated protein in the plastid can 
result in unwanted phenotypic effects, which can lead to even more severe pleiotropic effects if 
protein accumulation in the plastid increases (Oey et al., 2009). Recently, the group of Daniell 
reported protein accumulation up to 70% total leaf protein without negative effects on the plant 
(Ruhlman et al., 2010). Our results, however, are in agreement with studies which showed that 
comparably small amounts of heterologous protein accumulation can result in pleiotropic effects 
in the plant (Lössl et al., 2003, Magee et al., 2004, Waheed et al., 2011).  
The expression of eGFP in tobacco plastids was reported before without any mentioned 
phenotypic effects (Newell et al., 2003). This was confirmed by our control plant expressing eGFP 
only. When CPPs were coupled to eGFP in our study, the transplastomic plants’ phenotype was 
not greatly altered. However, effects like male sterility and impaired capsule development 
occurred in two out of nine lines (CPP7_eGFP and CPP9_eGFP). The underlying mechanism is 
currently not known. It seems however that the observed pleiotropic effects do result from a 
combination of the single CPP and the respective protein, which phenotypic outcome cannot be 
predicted. This is supported by the PAP1 lines. Expression of the Arabidopsis thaliana MYB 
transcription factor PAP1 resulted in chlorosis in the control line (PAP1 without CPP). 
Interestingly, when CPPs were coupled to PAP1, resulting fusion protein expressing lines either 
resembled WT (CPP1_PAP1) or showed even more pronounced pleiotropic effects (CPP3_PAP1). 
Discussion 43 
Plants aimed for the clinical trial, CPP_PAH (vector series III), exhibited the most profound 
consequences of fusion protein expression, spanning from normal growth (CPP2_PAH), to a dwarf 
phenotype (CPP3_PAH) and no regeneration at all (control_PAH without CPP). For this group, an 
interference of the heterologous protein with the amino acid metabolism of the organelle cannot 
be excluded. Although PAH was recently reported only to be present in gymnosperms, mosses 
and Chlamydomonas (Pribat et al., 2010), one might speculate that human PAH is functional when 
it is expressed in the plastid of a higher plant. Although the human co-factor BH4 is missing, 
plastids were reported to be rich in 10-formyltetrahydrofolate (10-formyl THF, Orsomando et al., 
2005). 10-formyl THF was identified as a co-factor for the enzyme in non-flowering plants 
(Pribat et al., 2010) and is also present in higher plants (Collakova et al., 2008). The observed 
phenotypes may therefore possibly result from a functional PAH enzyme in the plastid, in which 
the N-terminal fused CPPs attenuate PAH action. According to this hypothetical model, 
CPP2 hinders the function of the enzyme in the plastid which results in a WT phenotype. 
Accordingly, CPP3 does not completely interfere with PAH action and the plant shows the 
observed stunted bulky growth. A control plant, PAH without CPP, cannot be regenerated. 
Phenylalanine is converted to tyrosine which leads to the inability to regenerate the control PAH 
plant. Such explanation for the phenotypic consequences of CPPx_PAH lines is supported by the 
observation that CPPs can interfere with the function of their cargo (Dowdy, 2006). 
Although the expression of CPP fusion proteins turned out to be feasible in the plant, an issue that 
still needs to be optimized is the level of protein accumulation in the transplastomic lines. 
In principle, and in contrast to nuclear transformants which, with some exception, commonly 
accumulate as little as 0.01-0.4% TSP (Molina et al., 2004), the expression of transgenes from the 
plastid today enables to achieve protein accumulation up to 70 % TSP (Oye et al., 2009).  
To maximize expression levels of CPP fusion proteins in our study, we optimized the CCPx_eGFP 
expression cassettes in terms of codon-usage and structural elements for the expression in 
tobacco plastids (GENEART). In addition, expression cassette elements were chosen that were 
reported to confer high protein expression in the plastid (Scharff, 2002). However, despite this 
optimisation, protein accumulation levels were below what we had expected.  
In vector series I, CPPx_eGFP, high CPP fusion protein accumulation was probably hindered due to 
a directed repeat the underlying transformation vector pKCZglpk forms with the tobacco 
plastome (Scharff, 2002, Zou et al., 2003). This direct repeat is enabled through the use of tobacco 
rrn promoter (Prrn, plastid 16S rRNA promoter) in the transformation vector pKCZglpk 
(Zou et al., 2003). Upon site-specific integration, a 91 bp Prrn direct repeat is established with the 
native Prrn in the plastome and consequently recognized by plastid recombination machinery. 
This can lead to loop-out recombination events (Koop et al., 2007), which were confirmed for 
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vector series I by the detection of the recombined transcript (not shown). Although no vector 
elements are affected, the recombination affects the coding regions for 16S rRNA, 23S rRNA, 
4.5S rRNA, 5S rRNA, tRNA-Isoleucine, tRNA-Alanine. Despite this unfavorable condition, 
CPP7_eGFP showed detectable CPP fusion protein accumulation in the Coomassie gel (Figure 9) 
and at the whole plant level by the bare eye upon UV illumination (not shown).  
To overcome this structural limitation, the insertion site for homologous transformation vector 
integration was changed from trnN / trnR (Zou et al., 2003) to trnfM / trnG (Ruf et al., 2001) in the 
transformation vector intermediate pUC18(C) (Figure 14). However, for both resulting vector 
series (series II and series III), protein accumulation levels were not increased. Low fusion protein 
yields were observed for both CPPx-PAP1 (Figure 20) and CPPx-PAH (Figures 23, 25). 
This raises the question, whether low protein accumulation levels are common feature of CPP-
fusions protein expression in plastids or if rather structural determinants of the expression 
cassette are more important for the observed low yields. On which level the different CPPs / CCP 
fusion proteins or the vector design (Figure 4) exert an effect on the final level of protein 
accumulation awaits to be determined. Codon-optimisation was reported to increase protein 
accumulation only a few-fold in higher plants (Ye et al., 2001, Tregoning et al., 2003), whereas 
optimisation of translation control signals affect protein accumulation in a 10,000-fold range 
(Maliga, 2002). Bock and Warzecha (2010) conclude that not accumulation of stable transcript, 
but rather translational efficiency and protein stability limit protein accumulation. In a systematic 
approach to identify determinants of protein stability in chloroplasts, the importance of  
N-terminal amino acid residues after the start codon was highlighted (Apel et al., 2010).  
Among these are N-terminal determinants of stability are targeting sequences and purification 
tags. These elements consequently affect protein stability and subsequent protein accumulation 
in transplastomic plants (Elghabi et al., 2011). One might speculate that the combination of a His-
tag with the varying CPPs upstream of the respective fusion protein partner decreases protein 
stability and largely accounts for the low protein accumulation in the vector series I to III. 
Besides the need to increase CPP fusion protein accumulation, the phenotypic effects, which 
already resulted from low CPP fusion protein accumulation levels, suggest the use of an inducible 
system for future approaches. Although previous reports of inducible systems were still 
challenged by unsolved problems like low expression levels and promoter leakage in the non-
induced state (Koop et al., 2007), inducibility represents a key achievement when it comes to 
heterologous protein expression in plants. Equally important for the plants to accept foreign 
protein expression in their organelle is public acceptance in this regard. A functional inducible 
system could account for public concerns which are connected with the constitutive production of 
heterologous proteins in plants. Respective main concerns are not connected with a plants’ 
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overall gene content but rather if a gene in question is expressed or not. The use of an inducible 
system has the potential to account for those demands. In addition it could help studying the 
detailed effect of PAH and CPPx-PAH fusions on the plastid. 
3.2 CPP fusion proteins are entrapped in the organelle  
The current study marks the first expression of CPP fusion proteins in the plastid. Performing such 
a study is not only exciting from the perspective, that two fields, co-existing now for more than 
twenty years, get to know the chances and benefits the other field offers. We, from a plant 
biology point of view were interested in the effect of CPP fusion protein expression in the 
organelle, especially in terms of CPP fusion protein distribution.  
A number of mechanisms were proposed for CPP transduction spanning from direct modes 
(energy-independent) to endocytic modes (based on endocytosis, energy-dependent), 
both between and within single CPPs (see introduction 1.5). Which mechanism is exactly exploited 
depends on a number of factors (van den Berg and Dowdy, 2011) and the read-out of an 
experiment is not per se predictable (Holm et al., 2011). Although the majority of recent data 
after artefact discovery in the year 2001 (Lundberg and Johansson, 2001) supported an endocytic 
mode of uptake especially for CPP fusion proteins (Trabulo et al., 2010), there are still reports 
providing evidence for direct penetration modes of CPP fusions (Hariton-Gazal et al., 2003, 
Rosenbluh et al., 2004, Chang et al., 2005, Cermenati et al., 2011). Such a direct mode of 
transduction could result, in terms of plastid expressed CPP fusion proteins, in a transfer of CPP 
fusion protein from the organelle to the cytosol.  
In the past, endocytosis-free models like the transduction in organism not capable of endocytosis 
(Nekhotiaeva et al., 2004, Geueke et al., 2005, Liu et al., 2008) and CPP escape / transduction 
experiments with artificial lipid vesicles (Magzoub et al., 2005, Björklund et al., 2006, Bárány-
Wallje et al., 2007, Säälik et al., 2011) were employed in CPP research to shed light on CPP 
mechanism. The expression of CPP fusions and studying their potential escape from the plastid as 
enclosed organelle is in line with such approaches. 
Recently, the transfer of dually located proteins (proteins with dual location in different 
compartments of cell) from mitochondria and chloroplasts to other cellular compartments has 
gained increased attention (for review: Krause and Krupinska, 2009, Pfannschmidt, 2010). 
One major group of these dually located proteins has DNA binding ability (transcription factors, 
telomere binding proteins) - a feature which is also characteristic for many CPPs, which are often 
derived from transcription factors (Heitz et al., 2009). The association of CPPs with DNA is 
mediated by the net positive charge of their cationic sequence.  
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Interestingly, in a recent study (Isemer et al., 2012) plant transcription factor Whirly1 was 
reported to be relocated from the plastid to the nucleus. The underlying mechanism of 
translocation is currently unknown. This draws attention to parallels with the maize homeobox 
transcription factor KNOTTED1, which was first shown to travel between plant cells and later on 
shown to function as CPP in animal cells (see introduction 1.7).  
Although further evidence in Whirly1 translocation is needed and the detailed mechanism is still 
elusive, the report demonstrates the growing interest in studying routes from plant organelles to 
the cytoplasm and the nucleus. Once established, such route could potentially be used for an 
export of proteins from the organelles to the cytosol. A route, regarded highly desirable for both 
basic and applied science. In basic science it would offer the possibility to study plastid to nucleus 
communication in e.g. in terms of retro signaling. For applied approaches it would allow to couple 
the high expression capacity of the plastid with the glycosylation machinery mediated from the 
cytosol. This would be of great interest for the expression of complex human proteins in the 
plastid, since glycosylation is a feature plastids do not offer. 
However, when we first studied such CPP-mediated translocation scenario from the plastid to the 
cytosol with the CPPx-eGFP fusion proteins by optical means (vector series I), it became obvious 
that a second system was desirable. It was discovered that the optical eGFP system was amenable 
to artefacts (Figure 8). Water-infiltration turned out to disrupt cell integrity which resulted in 
fusion protein release from the plastid to the cytoplasm. Consequently, although first data 
suggested differences between the single CPPx-eGFP fusions, artefacts could be generated in all 
lines including the control. When dividing protoplast-derived cells were studied, CPP-eGFP signals 
were contained in the chloroplast / stromule network (Figure 7). However, even in this system 
artefacts were detected (Figure 8). Artefact and stromule detection were a function of the 
expression strength which varied between but also within the CPPx_eGFP lines. 
The second line of evidence which was established in terms of CPPx-fusion protein distribution 
was the PAP1 system. The proposed system (Figure 15) is per se considerably elegant since it is 
designed to provide a biological read-out which does not require any sample handling. 
However, also with this vector series, no differences between the control_PAP1 and the 
CPPx_PAP1 lines were detected when scored visually (Figure 19) and when judged from the thin 
layer chromatography (not shown). This is in line with the result from vector series I (CPPx_eGFP) 
and suggests no fusion protein escape from the plastid by a direct mechanism of CPP 
translocation. This is in accordance with the majority of studies in the CPP field, which reported 
endocytic routes of transduction for CPPs coupled to large cargoes. Among these endocytic 
routes, macropinocytosis has increasingly gained importance for transduction (Kaplan et al., 2005, 
Nakase et al., 2007). This was confirmed by recent data from the Langel lab (Mäger et al., 2012) 
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and is also supported by the majority of contributions from the plant sector (Chugh et al., 2010, 
Qi et al., 2011). It seems that CPP definition keeps evolving and an updated version was reported 
to be suggested in the near future (Mäger et al., 2012). 
Taking provided data into account, one could argue, that the general functionality of the 
physiological PAP1 system remains to be proven. If there is leakage from the organelle, and the 
fusion proteins successfully access the cytosol, CPPx-PAP1 proteins still have to enter the nucleus 
to provide a positive read-out. Cermenati et al. (2011) reported FITC labeled Tat (CPP3) 
accumulation in the nucleus of insect cells, however no Tat-eGFP fusion protein transduction in 
the nucleus. The authors state structural reasons of eGFP for this phenomenon, which, however, 
do not necessarily apply to the transcription factor PAP1.  
For future studies, it could be interesting to test if protein fusions to lytic peptides, the class of 
peptides with even more disruptive effect on membranes, offer a tool to deliver cargoes to and 
from compartments. In addition, exciting candidates like plant transcription factors should be 
studied as fusions to GFP, most importantly in the case of Whirly1.  
Taken together, from the current perspective, combined results from the eGFP and the PAP1 
vector series suggest that none of the CPP fusion protein combinations was leaking from the 
plastid. However, when we tested for “classical” membrane transduction we were surprised that 
we found no transduction properties at all. 
3.3 Do plant-produced CPP-fusion proteins penetrate into 
protoplasts and human cells? 
The use of CPPs in plant biology marks a very recent expansion of the CPP field. CPP-mediated 
manipulations carried out in molecular plant science were so far performed from the “outside”, 
trying to manipulate plant cells in terms of protein, RNA and more recently DNA delivery. 
The benefits of CPP use in plant science have been shown in many cases and a first 
comprehensive review in the field provides an overview about the achievements (Chugh et al., 
2010).  
Besides introducing the concept of CPP fusion protein expression in plants, we were interested 
whether or not our plastid-expressed CPPx-eGFP fusion proteins were able to penetrate into plant 
and human cells – the characterising feature of CPPs which is described throughout the CPP 
literature.  
However, the low CPPx-eGFP fusion protein accumulation in the plastids did not yield sufficient 
fusion protein for transduction experiments except for CPP7-eGFP (Figure 10). 
Consequently, recombinant CPP-eGFP fusion proteins were isolated from E. coli. This enabled us 
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to study the transduction of one plastid-produced and six bacterial-produced CPPx-eGFP fusion 
proteins. 
To our great surprise, we could not observe any transduction. There was no CPPx-eGFP 
penetration into tobacco protoplasts (Figure 11) and young tobacco leaf tissue (Figure 12). 
When CPPx-eGFP fusion protein transduction into human cell lines was studied, the same 
observation was made (Figure 13). Even altered experimental conditions (incubation time, 
concentration of fusion protein and buffer regime) did not change this result.  
This is not consistent with the majority of reports in the CPP literature in which fast, 
concentration dependent CPP uptake is reported. If one only refers to studies of CPP-(e)GFP 
fusion protein delivery, transduction was shown into human cells (Park et al., 2002, Yang et al., 
2002, Cao et al., 2002, Ryu et al., 2003, del Gaizo and Payne, 2003, Ferrari et al., 2003, Fittipaldi et 
al., 2003, Sengoku et al., 2004), into plants (Chang et al., 2005, Liu et al., 2008, Lu et al., 2010, Qi 
et al., 2011) and into insect cells (Cermenati et al., 2011). 
In our experiments, transduction experiments were carried out at concentrations of 1-10 µM with 
incubation times from 30 min to 24 h, at room temperature for plant cells and 37 °C for human 
cells – experimental conditions under which transduction is expected to occur according to the 
above mentioned literature. In addition, well studied CPPs were chosen for our approach  
(Table 1). Even if one takes into account that experimental CPP transduction results cannot be 
predicted (Holm et al., 2011) and that CPP read-outs can differ despite of the same experimental 
setup (Cai et al., 2006, Dupont et al., 2011), the results obtained raise serious questions and 
consequently draw the attention to studies where transduction failed. Reports on the 
unsuccessful transduction of CPPs are not dominant in the CPP literature. Leifert and Whitton 
(2003) review discrepancies in the transduction of Tat (CPP3), Penetratin (CPP4) and VP22 (CPP9) 
and attempt to explain transduction by well-established biological principles. Factors leading to 
contradictory experimental read-outs in CPP experiments were presented in a nice work by 
Fischer and co-workers (compare Figure 3 in: Fischer et al., 2005). Chauhan and co-workers (2007) 
review the CPP literature and identify factors for discrepancies in CPP research among which are: 
cell age, proteolytic degradation within the cell, permeability of cell type, conformational reasons, 
effects of time, nature of CPP-cargo linkage. Foerg and Merckle (2008) finally challenge the 
hypothesis of CPPs as unrestricted delivery tools and come to the conclusion that “the concept of 
CPPs as a universal tool in drug delivery needs to be abandoned”. Recently, Simon et al., 2010 
shed light on the on-going discrepancy why some groups reported successful transduction across 
brain-blood-barrier (BBB) and others did not. The authors observed efficient transduction across 
BBB was correlated with a disrupted state of the barrier following ischemic injury. For an intact 
BBB in their hands and others, Tat (CPP3) was not identified as an effective vehicle for trans-BBB 
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delivery. The achievements in the application of CPPS in hypoxia and ischemia were recently 
reviewed (Dietz, 2011). 
Why all CPPx-eGFP fusion proteins expressed in our hands were unable to penetrate protoplasts 
and human cells under all tested experimental conditions is currently beyond our knowledge. 
It is interesting to note that although the combination of CPP with eGFP caused pleiotropic effects 
in the plant upon expression in the plastid (3.1), no differences in transduction behaviour were 
observed. However, these pleiotropic effects do not necessarily account for a functional fusion 
protein. To which degree the low expression levels are correlated to the absent transduction 
ability remains as a further question. To confirm the integrity of our CPP-eGFP fusions, proteins 
used in our transduction studies were sequenced. Although trypsin digest led to tiny fragments 
and e.g. an inability to detect CPP1, which consists of eight arginine residues, data confirmed that 
CPPs were present and correctly fused to eGFP.  
Essential elements of the CPP fusion cassette in our study were arranged according to the design 
of Han et al. (2000) and Kwon et al. (2000). Reported vector series was used by this group for the 
successful transduction of proteins fused to different CPPs in a number of studies (Jin et al., 2001, 
Park et al., 2002, Ryu et al., 2004, Eum et al, 2004, Kim et al., 2005, Song et al., 2008). 
Most importantly the group worked on unfixed cells and included trypsin-EDTA washings to avoid 
artefacts in their studies. In addition, the N-terminal His-tag did not interfere with the 
transduction ability of fusion proteins. 
The alternative fusion protein vector system which does not require cleavage of the N-terminal 
His-tag is pTAT-HA, provided by the Dowdy lab (Nagahara et al., 1998). This vector was used in the 
majority of CPP fusion protein studies but does solely rely on Tat (=CPP3) for transduction. 
For future approaches and to identify possible bottle-necks in our system, it would be interesting 
to integrate the pTAT-HA system in a chloroplast transformation vector and to test different 
combinations of CPPs fused to proteins. 
In plant biology, a potential application is CPP-mediated transformation vector delivery. 
It has been shown that CPPs can be used for the delivery and transient expression of DNA 
(Chugh and Eudes, 2008b, Chugh et al., 2009), stable transformation however was not achieved. 
Experiments in our laboratory towards the non-covalent CPP-mediated delivery of nuclear 
genome and plastid transformation vectors with company-synthesized CPPs (MPG, Morris et al., 
1999, MPGΔNLS, Simeoni et al., 2003) did not yield transplastomic plants. Recently, Ziemienowicz 
et al. (2012) reported the successful dimer-Tat-mediated delivery of a T-DNA, VirD2 and RecA 
nano-complex for the integration of transgenes into the genome of triticale. 
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3.4 Do CPP-PAH fusion proteins expressed in plastids exert a 
positive effect in vivo? 
The field of plastid transformation is characterised by approaches of both basic and applied 
aspects. Applied research for human health in the past focused mainly on the expression of 
vaccine antigens in the plastid. Oral application for the delivery of these plastid-expressed vaccine 
antigens and targeting to the mucosa via adjuvants is one of the main strategies for their 
application. Reports of other protein therapeutics are rare, especially since therapeutics like 
human enzymes require targeting to tissues and compartments beyond the mucosa. 
Besides reports by the Daniell lab making use of adjuvants like CTB and LTB for trans-mucosal 
delivery (Limaye et al., 2006, Ruhlman et al., 2007, Verma et al., 2010, Boyhan and Daniell, 2011), 
there are no reports of versatile carrier system which allows for cellular delivery in the 
transplastomic field.  
CPPs introduced in the present study offer a unique potential for cellular delivery of peptides and 
proteins and the huge, highly established field of CPPs can easily be connected to the plastid 
technology.  
To finally introduce CPP fusion protein expression in plastids / plants with a concrete example, 
we focused on the expression of CPP fusions to a human enzyme in the plastid. The ultimate goal 
was to show the value of such a plastid-expressed CPP fusion protein in the substitution of a 
non-functional enzyme in a clinical mouse model. The mendelian disorder phenylketonuria (PKU) 
and its committing enzyme phenylalanine hydroxylase (PAH) was selected due to its metabolic 
character, its clear connection to nutrition and the resulting long history of dietary treatment of 
the disease. The approach was coordinated with the help of Ania Muntau’s lab at Dr. von Hauner 
Children’s Hospital at LMU Munich, which has expert knowledge in the characterization and 
treatment of PKU. Vector cloning, plant regeneration and characterization were carried out in our 
laboratory, purification and testing of fusion proteins in the mouse model was thought to take 
place at the Muntau lab. 
However, when we tried to isolate CPP2-PAH fusion protein from greenhouse grown plants, 
no PAH fusion protein was detected in the analysed samples including the raw extract (Figure 25).  
The second transplastomic line, CPP3_PAH, which was established in the approach, showed a 
dwarf phenotype and consequently did not yield sufficient amounts of fusion protein for 
extraction. In addition, when this line was tested for TSP banding pattern, no CPP3-PAH-specific 
band was observed, which suggests fusion protein accumulation to less than 1% TSP also for this 
line (Figure 23). As discussed in 3.1, no transformant was obtained for the control vector (PAH 
without CPP).  
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At the moment, not much can be said about the value of the PKU system since CPP-PAH fusion 
proteins for testing are still elusive. Compared to the protein accumulation levels observed for the 
eGFP and PAP1 vector series, even lower CPP fusion protein levels were provided by the plant for 
PAH. It is established in the literature that PAH stability can be negatively affected in the presence 
of a His-tag. For this reason an MBP tag is preferred for purification (Dunja Reiß, personal 
communication). This might affect the per se low accumulation level in the plastid and lead to the 
protein degradation products which were observed in the gel filtration profile (Figure 25). 
This explanation is supported by the effect N-terminal elements exert on the stability of fusion 
proteins in plastids as suggested in 3.1 (Apel et al., 2010, Bock and Warzecha, 2010). 
In contrast to this are the results in the report which served as guideline for our approach. 
In this study, a His-tagged CPP3-PAH fusion was successfully expressed (in E. coli) and applied 
without constraints of degradation (Eavri and Lorberboum-Galski, 2007). Similar to our results and 
promoting rather an effect of the protein itself than of N-terminal elements, Belluci and co-
workers (2005) were unable to detect ß-zein accumulation in transplastomic tobacco after stably 
inserting the ß-zein gene in the plastome. 
Currently, the low protein accumulation levels of CPPx-PAH fusion proteins in this study are not 
promoting the manufacture of CPP-PAH fusions in plastids. As mentioned before, also for this 
vector series, inducible expression again turned out to be desirable since this could ensure plant 
regeneration upon vector delivery (PAH control) and a higher biomass in terms of the CPP3-PAH. 
Marker removal by the formation of a transient cointegrate (Klaus et al., 2004) was nicely shown 
in our study by the incorporation of the antibiotics selection cassette in the backbone of 
transformation vector pUC18(C) (Figures 21, 24). Towards a potential application, however, more 
studies are needed to address further safety related issues. We have observed substantial 
changes in CPP fusion protein expression levels within single lines as was concluded from CLSM 
microscopy (not shown). For the favoured oral application of fusion proteins in edible plants 
(Daniell et al., 2001), highly standardized doses of the active proteins are required. 
It is questionable if plants can meet these requirements, especially when grown in the field. 
In addition, more future focus must be drawn on the effects of the raw consumption of transgenic 
plant material. Lacking knowledge in terms of these questions currently favours the contained 
(facility-based) expression in plants with subsequent product purification, although higher costs 
do result from such procedure.  
As soon as these limitations are solved and requirements are met, contained expression of CPP 
fusions in plants will have the chance to become reality. The established field of CPP technology 
and the large number of clinical approaches suggest that CPPs could play a vital in plastid 
engineering in the future. 
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So far our study may serve as a starting point for future collaborations between the two fields. 
For future directions, reviews listed in the introduction (1.6) of this study suggest an impressive 
number of potential targets for the use of CPPs in the transplastomic field. To start with, a study 
addressing a direct comparison between adjuvant- and CPP-mediated delivery is of interest, since 
CPPs can be used for the delivery of antigens (for review: Brooks et al., 2010),  
a field classically targeted with adjuvants. A recent review highlights aspects of CPP-mediated oral 
delivery (Khafagy and Morishita, 2012). An additional route to test with extracts made of plants 
could be CPP-mediated transdermal delivery (Rothbard et al., 2000, Song et al., 2008, 
Lohcharoenkal et al., 2011). This could be of interest for the treatment of rare skin diseases like 
ichtyosis which suffer from insufficient treatment (Huber et al., 1995, Smith et al., 2006).  
In conclusion we have introduced CPP fusion protein expression in plants, more specifically in the 
plastid. Further work is needed to fine-tune the technique and to study long-term effects. If these 
requirements will be met and if the expression of CPP fusion proteins in plants will increasingly 
gain importance remains to be determined. 
 
 
 
 
 
 
 
 
 
4 Summary 
Plastid transformation is a valuable technique for both basic and applied science. In basic science 
the technique is used to study chloroplast function. Applied approaches deal with the potential of 
the plastid for the production of medicinal therapeutics, in most cases vaccine antigens coupled 
to adjuvants. Adjuvants are used for the trans-mucosal delivery of attached cargoes.  
Cell penetrating peptides (CPPs) emerged as valuable tools for the delivery of cell-impermeable 
cargoes across cell barriers more than twenty years ago. Although the exact mechanism of CPP 
penetration of cells is still discussed, the applied value of CPPs is documented in a number of 
clinical studies. Recently, scientists working in the CPP field launched a call for an alternative 
expression platform for CPP fusion peptides / proteins. Only a short time before, CPPs were 
introduced into plant science and some impressive first results, manipulating plant cells from the 
“outside”, were achieved. 
 The present study aimed at combining the fields of plastid transformation and CPPs from the 
“inside”. We report the first expression of CPP fusion proteins in a plant, more precisely in the 
plastid. The approach focused on three aspects of CPP fusion protein expression in the organelle: 
(A) the principal feasibility of CPP-fusion protein expression in the plastid, (B) the location of CPP 
fusion proteins in the plant cell upon plastid-based expression and (C) the use of plastids for the 
manufacture of CPP fusions to provide an alternative to the bacterial expression system.  
Nine prominent CPPs were employed in three vector series to investigate these aspects. In vector 
series I the selected CPPs were fused to the fluorescent protein eGFP to provide an optical read-
out; in vector series II, the CPPs were fused to Arabidopsis MYB transcription factor PAP1 to 
provide a biological read-out and in vector series III, two CPPs were fused to the human enzyme 
PAH to introduce plant-based CPP fusion protein expression. 
Taken together, the expression of CPP fusion in the plastid turned out to be feasible. 
Transplastomic plants reached homoplasmy, produced viable seeds and stably inherited the 
desired trait to their progenies in a maternal fashion. Only low protein accumulation levels were 
detected. Pleiotropic effects occured at the low protein accumulation levels observed. 
Localisation of CPP fusion proteins was shown to be restricted to the plastid. An inability of CPP 
fusion proteins isolated from vector series I to penetrate protoplasts, young plant tissue and 
human cell lines was revealed. The value of a plastid-based manufacture of CPP fusion proteins 
for clinical approaches failed to be demonstrated due to low fusion protein accumulation levels. 
Bottlenecks of the current study are discussed and suggestions are made to provide a framework 
for future efforts. 
5 Zusammenfassung 
Plastidentransformation ist eine wertvolle Technik sowohl für die Grundlagenforschung als auch 
für die angewandte Wissenschaft. In der Grundlagenforschung wird die Technik verwendet um 
die Funktion von Chloroplasten zu studieren. Angewandte Aspekte der Technologie beschäftigen 
sich mit der Produktion von Therapeutika für die menschliche Gesundheit. Dabei handelt sich in 
den meisten Fällen um Impfstoff-Antigene, die an Adjuvantien gekoppelt sind. Adjuvantien 
werden zur Vermittlung der Antigene über die Mucosa eingesetzt. Vor mehr als zwanzig Jahren 
wurden mit zell-penetrierenden Peptiden (cell penetrating peptide, CPP) wertvolle Tools 
eingeführt um membran-inpermeable Substanzen in die Zelle zu vermitteln. Obwohl der genaue 
Mechanismus, wie CPPs dies bewerkstelligen, immer noch diskutiert wird, ist der Wert von CPPs 
in einer Reihe von klinischen Studien dokumentiert. Vor kurzem äußerten Wissenschaftler in der 
CPP Forschung den Wunsch nach alternativen Plattformen für die Produktion von CPP-
Fusionspeptiden und -proteinen. Nur kurze Zeit zuvor wurden CPPs das erste Mal in den 
modernen Pflanzenwissenschaften eingesetzt. Dies umfaßte Manipulationen von Pflanzenzellen 
von „außen“ und welche in beeindruckenden ersten Ergebnissen dokumentiert wurden. 
Die vorliegende Studie konzentrierte sich auf eine Kombination der Felder der 
Plastidentransformation und der CPPs von "innen". Wir berichten die erste Expression von CPP-
Fusionsproteinen in einer Pflanze, genauer gesagt in den Plastiden. Drei Aspekte der Expression 
von CPP-Fusionsproteinen in den Organellen wurden untersucht: (A) Die prinzipielle Machbarkeit, 
(B) die Verteilung von CPP-Fusionsproteinen in der Pflanzenzelle bei Expression in den Plastiden, 
und (C) die Eignung von Plastiden zur Herstellung von CPP-Fusionsproteinen als eine Alternative 
zu dem bakteriellen Expressionssystem. 
Um diese Aspekte zu untersuchen wurden neun prominente CPPs in drei Vektor-Serien an 
verschiedene Proteine gekoppelt und in den Plastiden produziert. In Vektor-Serie I, wurden die 
CPPs an das fluoreszierende Protein eGFP fusioniert, um eine optische Nachverfolgung zu 
ermöglichen. In Vektor-Serie II wurden die CPPs an den Arabidopsis MYB Transkriptionsfaktors 
PAP1 fusioniert, um eine biologische Auslese zu ermöglichen. In Serie III wurden zwei CPPs an das 
menschliche Enzym PAH gekoppelt um auf die prinzipielle Möglichkeit einer pflanzen-basierten 
Produktion von CPP Fusionsproteinen hinzuweisen.  
Zusammengefasst, stellte sich die Expression von CPP-Fusionsproteinen in Plastiden als machbar 
heraus. Transplastomische Pflanzen erreichten Homoplastie, produzierten keimfähige Samen und 
vererbten die gewünschte Eigenschaft stabil an ihre Nachkommen. Nur geringe Ausbeuten von 
Fusionsproteinen wurden erzielt wobei pleiotrophe Effekte auftraten. Die Akkumulation von CPP-
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Fusionsproteinen war auf die Plastide beschränkt. Die Unfähigkeit von isolierten CPP-
Fusionsproteinen der eGFP Vektor-Serie in Protoplasten, junges Pflanzengewebe und humane 
Zelllinien einzudringen, wurde aufgezeigt. Der Wert einer plastiden-basierten Herstellung von 
CPP-Fusionsproteinen für klinische Ansätze konnte wegen einer zu geringen Ausbeute an 
Fusionsprotein nicht aufgezeigt werden. Einschränkungen der aktuellen Studie werden diskutiert 
und Vorschläge gemacht, um einen Rahmen für zukünftige Anstrengungen zu geben. 
 
 
 
 
 
 
6 Material and Methods 
6.1 Material 
Experimental work was conducted in molecular laboratories equipped with standard laboratory 
equipment, chemicals and consumables for cell and plant culture and analysis. Critical chemicals, 
additional equipment and the software used for this work are mentioned in the following. 
6.1.1 Chemicals and Enzymes 
Water was deionized by absorption and ultrafiltration (SG ultra-Clear, Barsbüttel, Germany) and 
autoclaved if necessary. Standard analytical (analytical grade) and tissue culture (for in vitro 
culture) chemicals were purchased from AppliChem (Darmstadt, Germany), Bayer Vital 
(Leverkusen, Germany), Duchefa (Harlem, Netherlands), Merck (Darmstadt, Germany), Serva 
(Heidelberg, Germay), Sigma-Aldrich (Taufkirchen, Germany). Critical compounds used in this 
work for cell / tissue culture sorted by supplier: 
  
AppliChem     Ampicillin, sodium salt     
Ca-Panthotenate   
D-Glucose  
Bayer Vital     Dimanin C   
Duchefa     B5 salts   
Cellullase R10      
D(+)-Biotin  
Macerozyme R10    
MS salts  
Phyto agar  
Pyridoxine-HCl  
Spectinomycin dihydrochlorid  
Sucrose       
Merck      Thiamine-HCl  
Serva      Insosit   
Sigma-Aldrich    Alginic acid     
Benzylaminopurine  
     Naphthalene acetic    
     Nicotinic acid   
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DNA and protein markers, DNA modifying enzymes and polymerases were purchased from MBI 
Fermentas (St. Leon-Rot, Germany), Finnzymes (Espoo, Finland), New England Biolabs (Frankfurt / 
Main, Germany), Promega (Mannheim, Germany), and Roth (Karlsruhe, Germany). 
6.1.2 Kits, Consumables, Equipment and Software 
 Kits 
 
Clone Jet    MBI-Fermentas, St. Leon-Rot, Germany  
Nucleo spin extract II   Machery and Nagel, Düren, Germany  
Nucleo spin plasmid   Machery and Nagel, Düren, Germany 
Prime-a-gene labelling system  Promega, Mannheim, Germany 
Plasmid Maxi Kit   Qiagen, Hilden, Germany 
 
 Consumables 
 
AB mouse anti-PAH   Calbiochem, Darmstadt, Germany 
AB Goat anti-mouse IgG HRP   Santa Cruz Biotechnology, Heidelberg, Germany 
DMEM (Gibco)    Life Technologies, Darmstadt, Germany  
Doppelseitiges Klebeband   Tesa, Hamburg, Germany 
Gene gun consumables   Bio-Rad, München, Germany  
HiLoad 16/60 Superdex 200 column  GE Healthcare, München, Germany 
HisTrap affinity column   GE Healthcare, München, Germany  
HiTrap Butyl HP column  GE Healthcare, München, Germany 
MicroSpin-Columns S-200 HR   GE Healthcare, München, Germany 
N+-Nylonmembran     Amersham Biosciences, UK 
Nescofilm    Roth, Karlsruhe, Germany 
Ni2+- agarose    Biontex, Martinsried, Germany 
Nitrocellulose membrane BA-S 85  Schleicher & Schuell, Dassel, Germany 
Novex NuPAGE Bis-Tris gel system Life Technologies, Darmstadt, Germany  
Optimem (Gibco)   Life Technologies, Darmstadt, Germany  
Polypropylene grids Scrynel PP2000  K.H.Büttner, Wasserburg, Germany 
RPMI Media 1640 (Gibco)  Life Technologies, Darmstadt, Germany 
Steril filter PES 0.22µm    Serva, Heidelberg, Germany  
Steril filter PES 0.22µm, 250 ml   Serva, Heidelberg, Germany 
Tissue culture tube 163160   Greiner, Solingen, Germany 
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 Equipment 
 
ÄKTApurifier     GE Healthcare, München, Germany 
Canon EOS 400D   Canon GmbH, Krefeld, Germany 
Centrifuge Universal II   Hettich, Tuttlingen, Germany 
Centrifuge Z323K    Hermle, Wehingen, Germany 
Clean bench HERA safe KS12  Thermo Scientific, Langenselbold, Germany 
Confocal microscope TCS SP5  Leica Microsystems, Wetzlar, Germany 
DIANA III imaging system   Raytest GmbH, Sprockhövel, Germany 
FACS Canto II     BD Biosciences, Heidelberg, Germany 
Leica DM 100     Leica Microsystems, Wetzlar, Germany    
Microcentrifuge Fresco 17              Heraeus, Hanau, Germany 
Microcentrifuge 5415   Eppendorf, Hamburg, Germany 
Osmomat O30    Gonotech GmbH, Berlin, Germay 
Particle-gun PDS-1000/He      Bio-Rad, München, Germany 
Sterilbank Hera Safe Typ KS12  Thermo Scientific, Langenselbold, Germany 
Sorvall RC6    Thermo Scientific, Langenselbold, Germany 
 
 Software  
 
Clone Manager Professional  Sci-Ed Software, Cary NC, USA 
Double digest    http://www.fermentas.com/en/tools/doubledigest 
Google scholar    http://scholar.google.de/ 
ImageJ 1.45    http://rsbweb.nih.gov/ij/ 
NCBI     http://www.ncbi.nlm.nih.gov/ 
Office 2010    Microsoft GmbH, Unterschleißheim, Germany 
Vector NTI 7.0    InforMax, Oxford, UK 
Windows 7    Microsoft GmbH, Unterschleißheim, Germany 
6.1.3 DNA and Organisms 
 Vectors 
 
o Custom gene synthesis   GENEART, Regensburg, Germany 
o pKCZglpK    Scharff, 2002 
o pPNG1014_MCS120   Waheed et al., 2011 
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o PSB419   Sharma and Dixon, 2005 
o pUC18    MBI-Fermentas, St. Leon-Rot, Germany 
o Oligos    Metabion, Martinsried, Germany 
 
Primer name Sequence 5' -> 3' (restriction sites underlined if present) 
GFP  rev GACGTCATTCCGGATCCAAGG 
INS**fwd TTAGCTGGTCGTGACCAAG 
INS**rev CACAGGCATCCCAGGTAATTC 
KNT1 fwd AACTAGTCCGCGGGCCGTCGTTC 
KNT1 rev TACAACTAGTGATATCTTAGAGCTCGT 
LF fwd CTACCTGCACCTGGACAGAAAG 
Pah fwd TTCTCGAGATGTCCACTGCGGTCCTG 
Pah NheI rev TTTTGCTAGCTTACTTTATTTTCTGGAGGGCACTG 
Pap1 fwd CTACCTGCACCTGGACAGAAAG 
Pap1 rev GACGTCATTCCGGATCCAAGG 
Pap1 proof rev GACGTCATTCCGGATCCAAGG 
Probe new CPP fwd GGTTTTGTTGGTTGGTTAATTG 
Probe new CPP rev CCTGTTTAGTCCCCTTCATTTC 
Probe v2 fwd GGTGATGGGCAATATCAG 
Probe v2 rev GCAGGTTGGTTACACCTA 
rbcL fwd AATTGCTAGCCTGCAGGCATGCAAG 
rbcL rev TTAGTACTTCCCGAGAGGTCACAATTCC 
 
 Organisms 
 
o E. coli 
XL1 blue (genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIqZ∆M15 Tn10 
(Tetr)] 
o Agrobacterium tumefaciens 
GV3101 (pMP90) (Koncz and Schell, 1986) 
 
o Tobacco 
Nicotiana tabacum L-cv. Petite Havana (wild-type, WT)   
 
o Human cell lines 
HeLa cells, Jurkat T cells, Pheonix cells (293 derived cell line) 
 
 
 
Material and Methods 61 
6.2 Methods 
6.2.1 Vector cloning 
Standard molecular manipulation techniques of DNA like restriction digest, agarose gel 
electrophoresis, purification of DNA from agarose gels, dephosphorylation and ligation were 
carried out as described by the supplier protocols or in Sambrook and Russell (2001). DNA of high 
purity for vector cloning and subsequent transformation of E. coli and tobacco was purified with 
kits from Machery-Nagel and Qiagen (see 6.1.2). Cloning work was confirmed by LMU Biocentre 
sequencing service.  
6.2.2 Transformation  
6.2.2.1 E. coli 
 Bacterial growth 
 
E. coli cells were cultured in LB medium at 37 °C under shaking for 180 rpm. Cell growth was 
monitored by measuring the optical density at 600 nm. For selective bacterial growth, sterile 
antibiotics (100 mg/l ampicillin, 75 mg/l spectinomycin) were added. 
 
LB medium 
5 g  Yeast extract 
10 g  Bacto-Trypton  
10 g  NaCl  
10 g  Bacto agar, for solid plates 
pH 7.0 with 1 M KOH, Q.S. 1 l, autoclave. 
 Competent cells 
  
A 5 ml E. coli XL1 blue pre-culture was grown overnight as described in ‘Bacterial growth’. 
The next day, 100 ml LB medium was inoculated with OD 0.1 and grown to OD 0.5-0.6. Cells were 
incubated on ice for 15 min and harvested by centrifugation at 7,000 rpm for 10 min at 4 °C. 
After resuspension in 20 ml RF1 the cells were further incubated on ice for 2 h. Cells were pelleted 
again and the pellet resuspended in 4 ml RF2 followed by ice incubation for 15 min. 50 µl aliquots 
were shock frozen in liquid nitrogen and stored at - 80 °C. 
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RF1 
15.0 ml  Glycerol  
0.9 g  MnCl2*2H2O  
0.295 g  KAc  
0.145 g  CaCl2*2H2O  
1.2 g  RbCl  
pH 5.8 with acetic acid, Q.S. to 100 ml with ultra-filtrated autoclaved H2O, sterile filtrate. 
 
RF2      
0.505 g  CaCl2*2H2O  
0.105 g  MOPS   
0.51 g  RbCl 
7.5 g  Glycerol 
pH 6.8 with 1 M NaOH, Q.S. to 50 ml with ultra-filtrated autoclaved H2O, sterile filtrate. 
 Heat shock transformation 
 
An aliquot of competent XL1 blue cells was thawed on ice. Up to 10 µl ligation product were 
added and the mixture was incubated on ice for 10 min. Heat-shock was performed for 45 s at 
42 °C, followed by incubation on ice for 2 min.  
Cells transformed with a vector harbouring an ampicillin resistance gene were plated 
immediately on solid LB plates with 100 mg/l ampicillin and grown over night. 
Cells transformed with a vector carrying aadA (spectinomycin resistance gene) were 
adjusted to 500 µl with LB medium, shaken for 1 h and pelleted by centrifugation 
(3 min, 2,000 rpm). Part of the supernatant was removed and harvested cells were resuspended 
in the remaining volume and plated on solid LB plates with 75 mg/l spectinomycin. 
6.2.2.2 Tobacco 
 Plant growth 
 
Tobacco seeds were surface sterilized (1 min 70% ethanol, 10 min 5% Dimanin C, 3 washing steps 
with sterile H2O) and air-dried in the clean bench. Seeds were germinated in high density on B5mod 
in an environmental chamber at 25 °C, 2000 Lux (Osram L58 W/25 Weiss/Universal, 16 h day). 
After one week, plants were separated in jars for continuous growth on B5mod in the same 
chamber.  
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For transformation by the biolistic method and for protoplast isolation, four to five week old  
wild-type (WT) donor plants were used.  
At the same age, WT and transplastomic lines were routinely transferred to the greenhouse for 
prolonged growth, flowering and seed development. 
 
B5mod (Dovzhenko et al., 1998)  
3.1 g  B5-salts  
10 ml   100x B5-vitamins (Gamborg et al., 1968)  
10 g               Inosit  
100 mg      Pyridoxine-HCl   
1 g           Thiamine-HCl 
100 mg          Nicotinic acid 
Q.S. to 1 l with ultra-filtrated H2O, store at -20 °C. 
0.983 g  MgSO4*7 H2O 
20 g  Sucrose  
5 g  Phyto agar  
pH 5.8 with 1 M KOH, Q.S. to 1 l with ultra-filtrated H2O, autoclave. 
 
 Transformation of the plastid genome 
 
Transformation of the plastid WT genome was performed by the biolistic method (BioRad 
PDS1000/He Biolistic Gene Gun) – either by the bombardment of tobacco leaves or by the 
bombardment of protoplast-derived microcolonies. 
 
o Leaves 
 
True leaves of aseptically grown four to five week old tobacco WT plants were placed with the 
adaxial side up on petri dishes with simple RMOP (composition see page 68) the day before the 
experiment and stored in the environmental chamber used for plant growth until the 
bombardment. 
 
o Protoplast-derived microcolonies 
 
For the bombardment of protoplast-derived microcolonies tobacco protoplasts were isolated and 
embedded in grids with alginate.  
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 Protoplast isolation 
 
Sterile grown true leaves of four to five week old tobacco WT plants were digested enzymatically 
for protoplast isolation. Leaves were cut in 1-3 mm stripes in 10 ml F-PIN for pre-plasmolysis (1 h). 
Medium was exchanged to the digestion medium (9.5 ml F-PIN + 250 µl 10% Macerozyme 
solution + 250 µl 10% Cellulase solution) and leaves were incubated at 25 °C in darkness 
for 14-16 h. The next day, protoplasts released from the digested leaf tissue were separated by 
filtration (Ø 100 µm mesh size), gently overlaid with 2 ml F-PCN and centrifuged for 10 min at 70g. 
The interphase (intact protoplasts) was transferred to a new tube and was adjusted to 10 ml with 
MMM. Protoplasts were counted and the desired number was pelleted (10 min at 50 g) for 
further processing (embedding, CLSM). 
 
F-PIN   Fast Protoplast Isolation Medium Nicotiana (Dovzhenko et al., 1998)  
100 ml  10x Macro MS-modified   
10.12 g  KNO3   
4.4 g            CaCl2* 2H2O  
3.7 g            MgSO4*7H2O  
1.7 g             KH2PO4  
Q.S. to 1 l with ultra-filtrated autoclaved H2O, store at - 20 °C. 
10 ml  2 M Ammoniumsuccinate  
   23.6 g  Succinic acid 
10.6 g            NH4Cl   
~ 22.4 g       KOH 
pH 5.8 (KOH), Q.S. to 100 ml with ultra-filtrated autoclaved H2O, sterile 
filtrate. 
10 ml  100x Micro MS   
4 g  Fe(III)-EDTA  
83 mg  KJ   
620 mg         H3BO3  
2.33 g              MnSO4* H2O  
860 mg           ZnSO4*7H2O  
25 mg             Na2MoO4*2H2O  
2.5 mg            CuSO4*5H2O  
2.5 mg             CoCl2*6H2O  
Q.S. to 1 l with ultra-filtrated autoclaved H2O, store at - 20 °C.  
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10 ml  100x PC-Vitamins  
   20 g          CaCl2*2H2O   
20 g               Inosit 
200 mg         Pyridoxine-HCl 
100 mg        Thiamine-HCl  
2 mg             Biotin  
200 mg        Ca-Panthotenate   
200 mg        Nicotinic acid  
Q.S. to 1 l with ultra-filtrated autoclaved H2O, store at -20° C.   
1.952 g  MES 
1 ml  Benzylaminopurine (1 mg/ml)   
100 µl  Naphthalene acetic acid (1 mg/ml)   
~ 130 g  Sucrose (to 550 mOsm) 
pH 5.8 with 1 M KOH, Q.S. to 1 l with ultra-filtrated autoclaved H2O, sterile filtrate. 
 
10% Macerozyme solution 
1 g  Macerozym R-10  
1.37 g  Sucrose 
Q.S. to 10 ml with autoclaved ultra-filtrated H2O, centrifuge full-speed, sterile filtrate 
supernatant. 
 
10% Cellulase solution 
1 g  Cellulase R-10  
1.37 g  Sucrose 
Q.S. to 10 ml with autoclaved ultra-filtrated H2O, centrifuge full-speed, sterile filtrate 
supernatant. 
 
F-PCN    Fast Protoplast Culture Medium Nicotiana (Dovzhenko et al., 1998)  
same basic composition as F-PIN, instead of 130 g sucrose, use: 
20 g  Sucrose  
~ 65 g  Glucose (to 550 mOsm) 
pH 5.8 with 1 M KOH, Q.S. to 1 l with ultra-filtrated autoclaved H2O, sterile filtrate. 
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 Embedding 
 
For grid bombardments of protoplast-derived microcolonies, isolated tobacco protoplasts were 
embedded in a 1:1 mixture of F-PCN with alginate and kept growing for about 7-10 days before 
transformation (16-32 cell stadium). Briefly, 500,000 isolated protoplasts in MMM were harvested 
by centrifugation (50 g, 10 min) and carefully resuspended in a mixture of 3 ml F-PCN with 3 ml 
F-Alginate. 625 µl were pipetted on a dry polypropylene grid (10x10 meshes) on a Ca2+-agar plate. 
The mixture was allowed to solidify for 1.5 h before the grids were transferred to 4 ml new F-PCN 
for 1 h. After adaption to F-PCN, the medium was removed and exchanged by 2 ml fresh F-PCN. 
Grids were incubated in darkness for 14-24 h at 25 °C. The next day, embedded protoplasts with 
regenerated cell wall were exposed to light for subsequent microcolony formation. One day 
before particle bombardment, grids with protoplast-derived microcolonies were placed on dishes 
with RMOP (see page 68) stored in the environmental chamber until the bombardment. 
 
F-Alginate  
137 mg  MES  
250 mg  MgSO4*7H2O   
204 mg  MgCl2*6H2O   
~ 7.7 g  Mannitol (to 550 mOsm) 
2.4 g  Alginic acid 
pH 5.8 with 1 M KOH, Q.S. to 100 ml with ultra-filtrated H2O, autoclave. 
 
MMM MES-Magnesium Mannit (Dovzhenko et al., 1998)    
1.952 g  MES 
1.250 g  MgSO4*7 H2O  
1.020 g  MgCl2*6 H2O  
~ 85 g  Mannitol (to 550 mOsm) 
pH 5.8 with 1 M KOH, Q.S. to 1 l with ultra-filtrated autoclaved H2O, sterile filtrate. 
 
Ca2+-agar  
2.94 g  CaCl2*2 H2O 
1.95 g  MES 
~ 82 g  Manniol (to 550 mOsm) 
10 g  Phyto agar  
pH 5.8 with 1 M KOH, Q.S. to 1 l with ultra-filtrated H2O, autoclave. 
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o Particle gun-mediated transformation  
 
Prior to transformation by the biolistic method, gene gun, parts and consumables were surface 
sterilized and air-dried in the clean bench.  
Next, transformation vector DNA was coated on gold particles. A stock of 0.6 µm gold particles 
(Biorad) was suspended in 100% enthanol (60 mg/ml) and stored at - 20 °C. 35 µl of the gold stock 
were transferred into an Eppendorf tube, and pelleted at 14,000 rpm for 10 s. The supernatant 
was removed, the gold pellet resuspended in 1 ml sterile water and pelleted again (14,000 rpm, 
1 min). The following steps were carried out on ice. 
The washed pellet was resuspended in a mixture of 230 µl water and 250 µl 2.5 M CaCl2, and 
25 µg of DNA (in water) were added. DNA was coated on gold particles by the addition of 
50 µl 0.1 M spermidine and incubation on ice for 10 min, while gently vortexing every 2-3 min. 
The stabilized complex was centrifuged for 1 min at 10,000 rpm and the supernatant was 
removed. The gold-DNA complex was washed two times with 600 µl of 100% ethanol by 
resuspension and centrifugation at 10,000 rpm for 1 min. The complex was taken up in 72 µl 
ethanol and 5.4 µl were pipetted on each macrocarrier placed in the macrocarrier holder and 
allowed to dry for a few minutes. Transformation was carried out using the following parameters: 
 
Pressure of helium:             1100 psi  
Rupture discs:                900 psi  
Distance rupture disc to macrocarrier:       8-10 mm  
Distance macrocarrier to stopping screen:      10 mm  
Distance stopping plate to leaf:          7 cm  
Vacuum:                 27-28 inHg  
 
o Tissue culture conditions 
 
2-3 days post bombardment, leaves were cut into small pieces and placed on RMOP (regeneration 
medium) with 500 mg/l spectinomycin as selective agents. After two weeks, enlarged leaf pieces 
were cut again and recultured on fresh RMOP selection plates. Cultivation continued 
(from now every 3-4 weeks transferred to a new plate) until green, putative transplastomic, 
primary shoots emerged from the bleached leaf pieces. Bombarded protoplast-derived 
microcolonies were subcultured according to the same regime. 
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RMOP (Svab et al., 1990)  
4.4 g  MS-salts  
10 ml  100x NT-Vitamins  (Nagata und Takebe, 1971)       
10 g           Inosit  
100 mg         Thiamin-HCl 
Q.S. to 1 l with ultra-filtrated H2O, store at - 20 °C.   
1.0 ml  Benzylaminopurine (1 mg/ ml)   
100 µl  Naphthalene acetic acid (1 mg/ ml)   
30.0 g  Sucrose  
5.5 g   Phyto agar  
pH 5.8 with 1 M KOH, Q.S. to 1 l with ultra-filtrated H2O, autoclave. 
 
 Transformation of the nuclear genome 
 
Transformation of the nuclear genome was performed according to Horsch et al. (1985). 
Agrobacterium GV3101 harboring plasmid PSB419 was a kind gift from Richard Dixon (Sharma and 
Dixon, 2005).  
6.2.3 Transgenic plants 
6.2.3.1 Transplastomic lines 
 
Primary shoots emerging from bombarded leaves or microcolonies were isolated and transferred 
to fresh RMOP medium (6.2.2.2) for cyclization. Cyclization, i.e. the repeated regeneration of 
heteroplasmic leaf material on RMOP plates with selection pressure (500 mg/l spectinomycin), 
was carried until homoplasmy was achieved.  
6.2.3.2 Nuclear transformants 
 
Nuclear transformants (T0) obtained by Agrobacterium-mediated transformation were allowed to 
self in the greenhouse. Resulting seeds (T1) were sterilized and germinated on B5mod. 
Transformants were separated and grown in the greenhouse to produce T2.  
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6.2.4 Molecular analysis 
6.2.4.1 DNA isolation from plant tissue 
 
 Quick protocol 
 
About 100 mg of leaf tissue was ground in a screw cap tube with glass beads and 400 µl extraction 
buffer. Tubes were centrifuged for 15 min at 15,000 rpm and 330 µl of the supernatant were 
transferred to a new tube with an equal volume of isopropanol. After mixing and 10 min 
incubation at -20 °C, the DNA was pelleted by centrifugation (30 min, 15,000 rpm). 
The supernatant was removed and the pellets air-dried. A final volume of 40 µl sterile water was 
added to the tubes without disturbing the pellet. Tubes were stored at 4 °C overnight prior to 
PCR. For immediate analyses, about 1 h is sufficient for resolving the DNA from the pellet. 
 
Extraction buffer (Quick and Dirty) 
0.2 M   Tris-HCl (pH 7.5) 
0.25 M   NaCl 
0.025 M EDTA 
0.5% (w/v) SDS 
Use ultra-filtrated H2O, autoclave. 
 
 2x CTAB 
 
400 mg of fresh leaves were ground in liquid nitrogen. 2x CTAB (1 equal volume) was added to the 
ground powder in a 2 ml Eppendorf tube and the frozen samples were allowed to thaw (aided by 
short vortexing). Cells were lysed in a water bath at 65 °C for at least 1 h. One volume of 
chloroform was added and the tubes were rotated 30 min at RT. Samples were centrifuged for   
20 min at 15,000 rpm and the RNA in the supernatant was digested (10 µl RNAse; 10 µg/ml,  
30 min, 42 °C), After a second chloroform extraction step, the DNA in the supernatant was 
precipitated by incubation with 0.7 vol isopropanol (30 min, - 20 °C) and centrifugation (30 min at 
15,000 rpm, 4 °C). DNA was washed two times with ethanol, air-dried, redissolved in 60 µl sterile 
water and frozen at - 20 °C. 
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2x CTAB-Extractionbuffer  
200 mM  Tris-HCl (pH 8.0)       
2% (w/v) CTAB                 
20 mM   EDTA            
1400 mM  NaCl              
1% (w/v) Polyvinylpyrrolidon (40 kDa)    
Use ultra-filtrated H2O, autoclave. 
6.2.4.2 Polymerase chain reaction  
 
DNA fragments for cloning purposes were amplified with Phusion polymerase (Finnzyme), while 
Taq polymerase was used for colony PCR and for screening transplastomic lines (MBI Fermentas). 
Reaction conditions were adapted to the oligos used for amplification, the length of the PCR 
product and the polymerase. PCR products were analysed on agarose gels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Taq Polymerase 
2.0 µl (10x) 
1.6 µl 
0.4 µl 
0.4 µl 
0.4 µl 
0.2 µl 
100 ng 
Q.S. 20 µl 
 
Heated Lid 112.0 °C 
95.0 °C for 5 min 
30-35x 
95.0 °C for 30 s 
Anneal for 30 s 
72.0 °C for elongation 
End  
72 °C for 5 min 
Store at 4 °C 
 
Phusion Polymerase 
10 µl (5x) 
/ 
1 µl 
2.5 µl  
2.5 µl  
0.5 µl  
100 ng 
Q.S. 50 µl 
 
Heated Lid 112.0 °C 
98.0 °C for 30 s 
30-35x 
98.0 °C for 10 s 
Anneal for 30 s 
72.0 °C for elongation 
End 
72 °C for 10 min 
Store at 4 °C 
 
Buffer 
MgCl2 
dNTP (10 mM) 
Oligo fwd (10 pmol/ul) 
Oligo rev (10 pmol/ul) 
Polymerase 
Template 
Water 
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6.2.4.3 Southern blot analysis 
 
2 µg of CTAB-extracted DNA was digested with an appropriate restriction enzyme for 4 h and 
separated on an agarose gel at 10-30 Volt overnight. The next day, DNA was transferred to a 
positive charged nylon membrane via blotting the gel in an alkali environment (0.4 M NaOH). The 
gel was placed on the blotting aperture, followed by the membrane, two layers of Whatmann 
paper, several layers of tissue paper and a weight on top to apply pressure. After blotting, the gel 
was checked for complete transfer using UV illumination. The membrane was washed with 2x SSC 
until a neutral pH was achieved, air-dried, UV-cross linked and stored at RT until hybridization.  
For hybridisation probes were PCR amplified, kit extracted and adjusted to 5 ng/µl. Radioactive 
labeling was performed with α-32-P-dCTP using the prime-a-gene labeling system (Promega) as 
indicated by the manufacturer. Radioactively labeled probes were purified via MicroSpin-Columns 
S-200 HR (GE Healthcare), denatured for 3 min at 100 °C and put on ice. After pre-hybridization 
for 1 h at 65 °C in hybridization buffer, the membrane was incubated with the labeled probe in 
7.5 ml hybridization buffer at 65 °C overnight. 
Unspecifically bound probe was removed the next day by washing steps with increasing 
stringency (1x 30 minutes with 0.5x SSC-buffer, 0.1% (w/v) SDS at 60 °C, 2x 30 minutes with 
0.1x SSC-Puffer und 0.1% (w/v) SDS at 65 °C). The membrane was exposed to a phoshoimager 
screen and signals were detected with a BAS 1500-Phosphoimager (Fujifilm). 
 
20 x SSC 
3.0 M  NaCl 
0.3 M  Sodium citrate (pH 7.0) 
pH 7.0 with 1 M HCl, use ultra-filtrated H2O, autoclave. 
 
Hybridization buffer (Church and Gilbert, 1984) 
250 mM Na2HPO4 / NaH2PO4 (pH 7.5) 
7% (w/v) SDS 
Store at - 20 °C. 
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6.2.5 Macroscopic analysis 
6.2.5.1 Vegetative and reproductive growth 
 
Sterile seed-grown homoplastomic plants at an age of 3-4 weeks were transferred to the 
greenhouse and the growth was documented. At the time of flowering, floral buds were covered 
with paper bags to avoid cross pollination and the plants ability to self-pollinate and to develop 
seeds was monitored. 
6.2.5.2 Seed assay 
 
Seed-grown plants were crossed with and to WT plants. Resulting seeds were surface sterilized 
and germinated on B5mod medium (6.2.2.2) with and without 100 mg/l Spec. After 14 days, 
germination rates and seedlings phenotypes were documented. 
6.2.6 Microscopic analysis 
6.2.6.1 Fluorescence microscopy 
  
Expression strength of plant lines were routinely checked with a DM 1000 (Leica Microsystems). 
6.2.6.2 Confocal laser scanning microscopy (CLSM) 
 
Confocal laser scanning microscopy was performed on a TCS SP5 (Leica Microsystems), with an 
argon laser excitation at 488 nm (Leica EGFP) and detection at 496 nm-559 nm. 
 
 Leaves 
 
Leaves of seed-grown homoplastomic plants were water-infiltrated for microscopy. Water-
infiltration was carried out with a 50 ml syringe by first applying a vacuum to the leaf in the water-
filled syringe, followed by release of the vacuum and subsequent water in-flow into the leaf. An 
explant of the water-infiltrated leaf was cut, carefully mounted on slides with custom prepared 
spacers to avoid cover glass damage to the explant and studied by CLSM. 
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 Protoplast-derived cells 
 
Protoplasts of seed-grown homoplastomic plants were isolated and embedded in grids as 
described in 6.2.2.2. For the microscopy of early division stages of protoplast-derived cells, the 
grid was carefully removed from the cells embedded in alginate. Released alginate embedded 
cells were mounted on custom prepared slides and studied by CLSM. 
6.2.7 Chromatographic analysis 
 Thin-layer chromatography (TLC) 
 
200 mg leaf tissue from greenhouse-grown plants before flowering were shock frozen in liquid 
nitrogen and ground with glass beads in a screw-cap tube for 40 s at 5,000 rpm in darkness. 1 ml 
methanol:HCl [99.5:0.5 (v/v)] was added and the extraction was repeated. The extract was 
centrifuged for 5 min at 5,000 rpm and the supernatant was transferred to new tube. For analysis 
of anthocyanin content, cellulose analytic TLC plates (Sigma) were developed in concentrated 
HCl:formic acid:water (19.0:39.6:41.4). 
6.2.8 Biochemical analysis 
6.2.8.1 Extraction of total soluble protein (TSP) 
 
Total soluble protein was extracted from 100 mg leaf tissue of adult plants before flowering. 
Leaves were ground with glass beads in 500 ml ice-cold TSP extraction buffer in a bead mill for 
3 min at 250 rpm. The extract was placed on ice and centrifuged at 15,000 rpm for 30 min at 4 °C. 
The supernatant was taken as total soluble protein. 
 
TSP extraction buffer: 
50 mM   NaH2PO 4 / Na2HPO 4 (pH 7.0) 
10 mM   EDTA 
10 mM   2-mercaptoethanol 
0.1% (v/v)  Triton X-100 
1  Tablet Complete Protease Inhibitor Cocktail (Roche) per 10 ml 
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6.2.8.2 The Bradford assay 
 
5 µl of TSP was added to 1 ml 1 : 5 diluted Bradford solution in PBS. Samples were mixed and 
extinction at 595 nm was measured after 10 min. Protein content was calculated using a standard 
curve of known BSA concentrations. 
 
6.2.8.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Total soluble proteins were separated on discontinuous 10% denaturing polyacrylamide gels 
(with 20 mA for each mini gel) according to Laemmli. Gels were stained with Coomassie Brilliant 
Blue R-250 (Serva) on a shaker for 1 h. Background staining was removed with washing solution 
(10% acetic acid) and the gels scanned. 
6.2.8.4 Isolation of CPP fusion proteins 
 
CPP fusion proteins were isolated from E. coli cells and tobacco leaves. 
 
 from E. coli  
 
E. coli XL1 blue harbouring CPP_eGFP plastid transformation vectors were grown in 1-1.5 l LBAmp 
(see 6.2.2.1) cultures for fusion protein isolation. Cells were harvested (10 min, 4,000 rpm, 4 °C) 
and lysed in binding buffer by sonification. Purification was carried out by binding to Ni2+-agarose 
(Biontex) according to the manufacturer’s protocol. Isolated proteins were dialysed overnight 
50 mM Tris-HCl pH 8.0 at 4 °C, adjusted to 10% glycerol, shock-frozen and stored at - 80 °C. 
 
 from Nicotiana tabacum L. 
 
CPPx-eGFP fusion proteins were isolated from greenhouse-grown tobacco plants before 
flowering. About 50 g of FW plant material was ground in liquid nitrogen to a fine powder and 
total proteins extracted in ice-cold Tris-HCl pH 8.0. The extract was centrifuged at 15,000 rpm for 
20 min at 4 °C and the supernatant was vacuum filtrated (0.45 µM filter pore size). 
Prior to HIC column purification, ammonium sulfate precipitation was carried out. Unwanted 
proteins were precipitated by adjusting to 30% (w/v) ammonium sulfate. The eGFP fusion 
proteins were finally precipitated with 80% ammonium sulfate. The pellet was resuspended in 
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high salt buffer (50 mM Tris-HCl pH 8.0, 3 M NaCl) and applied to a HiTrap Butyl HP column 
(GE Healthcare). Binding and washing was carried out as suggested in application note 28-9192-12 
AB (GE Healthcare). Proteins were adjusted to 50 % glycerol and stored short-time at - 20 °C. 
Before transduction assays (6.2.9), purified proteins were dialyzed against 50 mM Tris-HCl pH 8.0 
at 4 °C overnight and quantified using the Bradford assay. 
 
 Fast protein liquid chromatography (FPLC) 
 
CPP-PAH fusion proteins were isolated from adult greenhouse plants. 20 g FW were ground to a 
fine powder and extracted in 40 ml sodium phosphate buffer (20 mM NaH2PO 4 / Na2HPO 4   pH 7.4, 
100 mM NaCl, 20 mM Imidazol). The extract was centrifuged at 15,000 rpm for 20 min at 4 °C and 
the supernatant was vacuum filtrated (0.45 µM pore size). The recombinant fusion proteins were 
purified on ÄKTApurifier (GE Healthcare) at 4 °C by loading crude extract on a HisTrap affinity 
chromatography column (GE Healthcare) equilibrated with sodium phosphate buffer and 
subsequent step-wise gradient elution was performed with the same buffer supplemented with 
500 mM imidazol. The fractions from affinity chromatography were analysed by gel filtration on a 
HiLoad 16/60 Superdex 200 column (GE Healthcare) equilibrated with 20 mM NaHEPES, pH 7.0 
containing 200 mM NaCl. 
6.2.8.5 Western blot 
 
Proteins were separated by SDS-PAGE (4-12% Novex NuPAGE Bis-Tris gel system, Invitrogen) at a 
constant voltage of 200 Volt for 90 min and subsequently blotted onto nitrocellulose membrane 
(BA-S 85; Schleicher & Schuell). The blocked membrane (5% milk powder in TBS-Tween) was 
incubated for 1 h with the primary antibody, mouse anti-PAH (1:1,000 dilution; Calbiochem), and 
1 h with the secondary, goat anti-mouse IgG HRP conjugated antibody (1:10,000 dilution; Santa 
Cruz Biotechnology). The blot was visualized with SuperSignal West Femto Substrate (Thermo 
Scientific) and chemiluminescence was monitored with a DIANA III imaging system (Raytest).  
6.2.9 Functional fusion protein assays 
6.2.9.1 Transduction of CPP fusion proteins into plant cells 
 
For the transduction of fusion proteins into protoplasts, 2.5 x 105 freshly isolated protoplasts 
(6.2.2.2) were incubated with protein concentrations from 1-5 µM in F-PCN for 1 h in darkness. 
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After incubation, protoplasts were washed two times with 10 ml F-PCN (10 min at 50 g) and 
studied by CLSM. 
In addition, transduction in partially digested young leaves was studied. Young leaves of 4-5 week 
old tobacco leaves were digested for 20 h. The resulting partially digested young leaves were 
washed two times in F-PCN and adjusted to 5 µM peptide in F-PCN. Incubation was carried out for 
24 h at RT in darkness. For analysis, leaf tissue was washed two times with F-PCN and studied by 
CLSM. 
6.2.9.2 Transduction of CPP fusion proteins into human cells 
 
To test transduction into human cells lines, suspension cells were kept in RPMI medium 1640 
(Gibco) with 10% FCS (fetal calf serum), 5% penicillin / streptomycin, 5% L- glutamin and 0.1% 
beta-mercaptoethanol at standard cell culture conditions (37 °C, 5% CO2) in cell culture flasks.  
For transduction assay 2 x 106 cells were washed twice with PBS, resuspended in Optimem 
medium (reduced serum medium, Gibco) and transferred into a 6-well plate. The fusion protein 
was added and incubated with the cells (37 °C, 5% CO2). At selected time-points, cells were 
washed twice with PBS and treated with trypsin for 15 min to remove membrane-bound fusion 
protein. Reaction was stopped by adding complete medium, in which cells were washed again. 
In order to quench the residual signal coming from unspecific membrane attachment, cells were 
resuspended in trypan blue (0.005% in PBS). Flow cytometric analysis was performed on a FACS 
Canto II (BD Biosciences). 
Adherent Phoenix (293 derived cell line) cells were kept in DMEM medium (Gibco) containing 10% 
FCS, 5% penicillin / streptomycin, 5% L-glutamine and 0.1% beta-mercaptoethanol at standard cell 
culture conditions in cell culture dishes. The day before the transduction assay 5 x 105 cells per 
well were seeded out in 6-well plates. Prior to transduction, cells were washed twice with PBS and 
incubated with Optimem for 1 h. The fusion protein was added and incubated with the cells  
(37 °C, 5% CO2). At selected time-points, cells were washed twice with PBS and treated with 
trypsin. The reaction was stopped with complete medium, in which cells were washed again.  
Finally cells were resuspended trypan blue (0.005% in PBS) and analysed by FACS. 
 
 
 
 
7 Abbreviations 
5’ UTR   5’-untranslated region 
aadA     3’ aminoglycoside-adenyltransferase, antibiotics selection gene 
AB   Antibody 
(Arg)9   Nonaarginine, CPP 
Amp   Ampicillin  
Arg   Arginine 
AS    Amino acid(s) 
bp/kb   Base pair(s)/ Kilo base pairs 
BH4   6-R-L-erythro-5,6,7,8-tetrahydrobiopterin 
BSA   Bovine serum albumin 
B5      Gamborg´s medium 
c    Centi 
CLSM   Confocal laser scanning microscopy 
CPP(x)   Cell penetrating peptide (x represents a CPP/number according to Table 1) 
CPPx-XXX   Fusion protein of given vector series 
CPPx_XXX  Vector or resulting plant line of given vector series 
CTAB   Cetyl trimethyl ammonium bromide 
CTB   Mucosa-binding subunit B of cholera toxin 
Da   Dalton 
DNA    Deoxyribonucleic acid   
E. coli    Escherichia coli 
EDTA     Ethylenediaminetetraacetic acid 
e.g.   Exempli gratia, Latin: "for example" 
(e)GFP    (Enhanced) green fluorescent protein 
ER   Endoplasmic reticulum 
ERT   Enzyme replacement therapy 
FACS   Fluorescence activated cell sorting 
FDA   Fluorescein diacetate 
FPLC   Fast protein liquid chromatography 
FW   Fresh weight 
g   Centrifugal force or gram 
G10L RBS  Ribosomal binding site from gene 10 leader sequence 
gfp14   First 14 amino acids of GFP 
Goi   Gene of interest 
GUS     β-glucuronidase 
h    Hour(s) 
HIC   Hydrophobic interaction chromatography 
His-tag   Polyhistidine-tag 
HIV-1   Human immunodeficiency virus type 1 
inHg   Inches of mercury 
INSR   Right insertion site 
INSL   Left insertion site 
k    Kilo 
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l   Litre 
Lab   Laboratory 
LB    Luria-Bertani 
LMU   Ludwig Maximilian University of Munich 
LTB   Escherichia coli heat-labile enterotoxin subunit B 
m    Milli or metre 
MCS   Multiple cloning site 
MES    2-(N-morpholino)ethanesulfonic acid 
min   Minute(s) 
(m)M    (milli)Molar = (milli)moles/l 
MOPS   3-(N-morpholino)propanesulfonic acid 
mOsm   Milliosmole 
n   Nano 
NEP   Nuclear encoded polymerase 
numbers 1 to 9  CPP abbreviation / number used in the text (compare Table 1.) 
OD   Optical density 
ORF   Open reading frame 
PAH   Phenylalanine hydroxylase 
PAP1   Production of anthocyanin pigment 1 
PBS   Phosphate buffered saline 
PCR   Polymerase chain reaction 
PEP   Plastid-encoded polymerase from rrn 16 
PKU   Phenylketonuria 
PNG10-   Fusion of PEP, NEP and G10L RBS 
psi    Pounds per square inch 
Q.S.    Quantity sufficient 
rbcL   Large subunit of the ribulose-bisphosphate carboxylase 
rpm   Revolutions per minute 
RT   Room temperature 
RNA   Ribonucleic acid 
SDS-PAGE   Sodium dodecyl sulfate polyacrylamide gel electrophoresis  
siRNA   Small interfering RNA 
Spec   Spectinomycin 
T   Thymus or trangenic plant generation or Thrombin site 
Tat   Transactivator of transcription (HIV-1), CPP 
TrbcL   rbcL terminator from C. reinhardtii 
tRNA   Transfer RNA 
TSP   Total soluble protein 
UV   Ultraviolet light 
WT   Wild-type 
w/v    Weigth per volume  
v/v   Volume per volume 
♀/♂   Female / male 
°C   Degree Celsius 
µ    Micro 
o
   Symbol for PAP1 vector series 
*   Symbol for PAH vector series or insertion site: trnfM / trnG 
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